<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders - Tan, ML - 2016 | Cochrane Library</title> <meta content="Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders - Tan, ML - 2016 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009398.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders - Tan, ML - 2016 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009398.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD009398.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders" name="citation_title"/> <meta content="May Loong Tan" name="citation_author"/> <meta content="Penang Medical College" name="citation_author_institution"/> <meta content="mltan@pmc.edu.my" name="citation_author_email"/> <meta content="Jacqueline J Ho" name="citation_author"/> <meta content="Penang Medical College" name="citation_author_institution"/> <meta content="Keng Hwang Teh" name="citation_author"/> <meta content="Hospital Sultanah Bahiyah" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="9" name="citation_issue"/> <meta content="10.1002/14651858.CD009398.pub3" name="citation_doi"/> <meta content="2016" name="citation_date"/> <meta content="2016/09/28" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009398.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009398.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009398.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Fatty Acids, Omega-3 [therapeutic use]; Fatty Acids, Omega-6 [therapeutic use]; Fatty Acids, Unsaturated [*therapeutic use]; Learning Disabilities [*drug therapy]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009398.pub3&amp;doi=10.1002/14651858.CD009398.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009398.pub3&amp;doi=10.1002/14651858.CD009398.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009398.pub3&amp;doi=10.1002/14651858.CD009398.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009398.pub3&amp;doi=10.1002/14651858.CD009398.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009398.pub3&amp;doi=10.1002/14651858.CD009398.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009398.pub3&amp;doi=10.1002/14651858.CD009398.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009398.pub3&amp;doi=10.1002/14651858.CD009398.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009398.pub3&amp;doi=10.1002/14651858.CD009398.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009398.pub3&amp;doi=10.1002/14651858.CD009398.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009398.pub3&amp;doi=10.1002/14651858.CD009398.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009398.pub3&amp;doi=10.1002/14651858.CD009398.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009398.pub3&amp;doi=10.1002/14651858.CD009398.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009398.pub3&amp;doi=10.1002/14651858.CD009398.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009398.pub3&amp;doi=10.1002/14651858.CD009398.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009398.pub3&amp;doi=10.1002/14651858.CD009398.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009398.pub3&amp;doi=10.1002/14651858.CD009398.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009398.pub3&amp;doi=10.1002/14651858.CD009398.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009398.pub3&amp;doi=10.1002/14651858.CD009398.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009398.pub3&amp;doi=10.1002/14651858.CD009398.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009398.pub3&amp;doi=10.1002/14651858.CD009398.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009398.pub3&amp;doi=10.1002/14651858.CD009398.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009398.pub3&amp;doi=10.1002/14651858.CD009398.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009398.pub3&amp;doi=10.1002/14651858.CD009398.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="9nGOjNGw";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD009398\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD009398\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009398\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009398\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ru","ms","ja","pl","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD009398.pub3",title:"Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders",firstPublishedDate:"Sep 28, 2016 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Developmental, Psychosocial and Learning Problems Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=9nGOjNGw&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009398.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009398.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD009398.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD009398.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009398.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD009398.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009398.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD009398.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009398.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD009398.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD009398.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD009398.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD009398.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD009398.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3806 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD009398.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009398.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009398.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009398.pub3/full#CD009398-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009398.pub3/full#CD009398-sec-0097"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009398.pub3/full#CD009398-sec-0015"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009398.pub3/full#CD009398-sec-0016"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009398.pub3/full#CD009398-sec-0025"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009398.pub3/full#CD009398-sec-0026"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009398.pub3/full#CD009398-sec-0059"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009398.pub3/full#CD009398-sec-0091"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD009398.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009398.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009398.pub3/appendices#CD009398-sec-0102"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009398.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009398.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD009398.pub3/media/CDSR/CD009398/table_n/CD009398StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD009398.pub3/media/CDSR/CD009398/table_n/CD009398StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009398.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009398.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009398.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009398.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009398.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD009398.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2016 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD009398.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009398.pub3/information#CD009398-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>May Loong Tan</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009398.pub3/information#CD009398-cr-0003">Jacqueline J Ho</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009398.pub3/information#CD009398-cr-0004">Keng Hwang Teh</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD009398.pub3/information/en#CD009398-sec-0134">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 28 September 2016 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD009398.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD009398.pub3">https://doi.org/10.1002/14651858.CD009398.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD009398-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009398-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009398-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009398-abs-0010">فارسی</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD009398-abs-0001" lang="en"> <section id="CD009398-sec-0001"> <h3 class="title" id="CD009398-sec-0001">Background</h3> <p>About 5% of school children have a specific learning disorder, defined as unexpected failure to acquire adequate abilities in reading, writing or mathematics that is not a result of reduced intellectual ability, inadequate teaching or social deprivation. Of these events, 80% are reading disorders. Polyunsaturated fatty acids (PUFAs), in particular, omega‐3 and omega‐6 fatty acids, which normally are abundant in the brain and in the retina, are important for learning. Some children with specific learning disorders have been found to be deficient in these PUFAs, and it is argued that supplementation of PUFAs may help these children improve their learning abilities. </p> </section> <section id="CD009398-sec-0002"> <h3 class="title" id="CD009398-sec-0002">Objectives</h3> <p>1. To assess effects on learning outcomes of supplementation of polyunsaturated fatty acids (PUFAs) for children with specific learning disorders.<br/> 2. To determine whether adverse effects of supplementation of PUFAs are reported in these children. </p> </section> <section id="CD009398-sec-0003"> <h3 class="title" id="CD009398-sec-0003">Search methods</h3> <p>In November 2015, we searched CENTRAL, Ovid MEDLINE, Embase, PsycINFO, 10 other databases and two trials registers. We also searched the reference lists of relevant articles. </p> </section> <section id="CD009398-sec-0004"> <h3 class="title" id="CD009398-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) or quasi‐RCTs comparing PUFAs with placebo or no treatment in children younger than 18 years with specific learning disabilities, as diagnosed in accordance with the fifth (or earlier) edition of the<i>Diagnostic and Statistical Manual of Mental Disorders</i> (DSM‐5), or the 10th (or earlier) revision of the <i>International Classification of Diseases</i> (ICD‐10) or equivalent criteria. We included children with coexisting developmental disorders such as attention deficit hyperactivity disorder (ADHD) or autism. </p> </section> <section id="CD009398-sec-0005"> <h3 class="title" id="CD009398-sec-0005">Data collection and analysis</h3> <p>Two review authors (MLT and KHT) independently screened the titles and abstracts of articles identified by the search and eliminated all studies that did not meet the inclusion criteria. We contacted study authors to ask for missing information and clarification, when needed. We used the GRADE approach to assess the quality of evidence. </p> </section> <section id="CD009398-sec-0006"> <h3 class="title" id="CD009398-sec-0006">Main results</h3> <p>Two small studies involving 116 children, mainly boys between 10 and 18 years of age, met the inclusion criteria. One study was conducted in a school setting, the other at a specialised clinic. Both studies used three months of a combination of omega‐3 and omega‐6 supplements as the intervention compared with placebo. Although both studies had generally low risk of bias, we judged the risk of reporting bias as unclear in one study, and as high in the other study. In addition, one of the studies was funded by industry and reported active company involvement in the study. </p> <p>None of the studies reported data on the primary outcomes of reading, writing, spelling and mathematics scores, as assessed by standardised tests. </p> <p>Evidence of low quality indicates that supplementation of PUFAs did not increase the risk of gastrointestinal disturbances (risk ratio 1.43, 95% confidence interval 0.25 to 8.15; two studies, 116 children). Investigators reported no other adverse effects. </p> <p>Both studies reported attention deficit hyperactivity disorder (ADHD)‐related behaviour outcomes. We were unable to combine the results in a meta‐analysis because one study reported findings as a continuous outcome, and the other as a dichotomous outcome. No other secondary outcomes were reported. </p> <p>We excluded one study because it used a cointervention (carnosine), and five other studies because they did not provide a robust diagnosis of a specific learning disorder. We identified one ongoing study and found three studies awaiting classification. </p> </section> <section id="CD009398-sec-0007"> <h3 class="title" id="CD009398-sec-0007">Authors' conclusions</h3> <p>Evidence is insufficient to permit any conclusions about the effect of PUFAs on the learning abilities of children with specific learning disorders. Well‐designed RCTs with clearly defined populations of children with specific learning disorders who have been diagnosed by standardised diagnostic criteria are needed. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD009398-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009398-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD009398-abs-0004">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD009398-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009398-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ja#CD009398-abs-0007">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD009398-abs-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD009398-abs-0008">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD009398-abs-0005">Русский</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD009398-abs-0003" lang="en"> <h3>Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders</h3> <p><b>Review question</b> </p> <p>We reviewed the evidence on the effects of polyunsaturated fatty acids (PUFAs), compared with placebo or no treatment, on reading, writing or mathematical abilities of children up to 18 years of age who have specific learning disorders. </p> <p><b>Background</b> </p> <p>Children with specific learning disorders are those whose abilities in reading, spelling, writing and mathematics are considerably below what is expected for their age, and whose problems are not a result of lower intelligence, inadequate teaching or social deprivation. A child may have a single disorder, such as a reading disorder, or a combined disorder, such as a reading and mathematics disorder. Children may have other problems too, such as attention deficit hyperactivity disorder (ADHD), along with a specific learning disorder. </p> <p>Polyunsaturated fatty acids are known to be necessary for normal brain development and function. The best known PUFAs are the omega‐3 fatty acids, which include docosahexaenoic acid (commonly known as DHA), but the omega‐6 fatty acids are also well known. Polyunsaturated fatty acids must be obtained from foods or supplements, as the human body cannot make them from other types of fat. Because they are needed for normal brain growth and development, PUFAs might help children with specific learning disorders. </p> <p><b>Study characteristics</b> </p> <p>The evidence is current to November 2015.</p> <p>We found two small studies involving 116 children that met our inclusion criteria. Both studies gave children a combination of omega‐3 and omega‐6 capsules as the intervention for three months. Most of these studies involved boys between 10 and 18 years of age ‐ one was conducted in a school setting, and the other at a specialised clinic. One of the studies was funded by the company that supplied the omega‐3 and omega‐6 supplements. </p> <p>Another study could not be included in this review because investigators added carnosine (an amino acid that is highly concentrated in the brain) to the PUFAs. Carnosine and PUFAs might have similar effects, so it would not be possible to separate the effects of the two ingredients. Review authors excluded five studies because it was not confirmed that a specific learning disorder was diagnosed in these children. </p> <p><b>Key results</b> </p> <p>None of the included studies reported effects of PUFAs on reading, writing, spelling or mathematical abilities of children. </p> <p>Evidence of low quality (because studies included few participants and showed evidence of bias) suggests that using PUFAs did not increase the risk of minor disturbances to the digestive system. Included studies reported no other types of adverse effects. </p> <p>Both studies reported on ADHD‐related behaviour. However, the format of available data did not allow us to readily combine them or to reach any conclusions. Included studies reported no other secondary outcomes. </p> <p><b>Conclusion</b> </p> <p>Evidence is not sufficient to support or refute the use of PUFAs in children with specific learning disorders. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD009398-sec-0097" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD009398-sec-0097"></div> <h3 class="title" id="CD009398-sec-0098">Implications for practice</h3> <section id="CD009398-sec-0098"> <p>To date, no RCTs have assessed the use of PUFAs alone for improvement in reading, writing or mathematics skills in children with specific learning disorders. At this time, evidence is insufficient to support or refute the use of PUFAs in children with specific learning disorders. </p> </section> <h3 class="title" id="CD009398-sec-0099">Implications for research</h3> <section id="CD009398-sec-0099"> <p>Adequately powered and well‐designed RCTs are needed to study the effects of PUFAs in children with specific learning disorders. The definition of specific learning disorders should be consistent with any well‐published, standardised criteria such as the<i>Diagnostic and Statistical Manual of Mental Disorders</i> (DSM‐5) (<a href="./references#CD009398-bbs2-0020" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth. (DSM‐5). Washingon DC: American Psychiatric Association, 2013. ">APA 2013</a>) and the <i>International Classification of Diseases</i> (ICD‐10) (<a href="./references#CD009398-bbs2-0092" title="World Health Organization. The ICD‐10 Classification of Mental and Behavioural Disorders. Clinical Descriptions and Diagnostic Guidelines. Geneva: WHO, 1992. ">WHO 1992</a>). As PUFA supplements may contain other active elements, it is important that these elements be given to both intervention and control groups. No optimal dosage of PUFAs can be recommended at the moment (<a href="./references#CD009398-bbs2-0073" title="SchuchardtJP , HussM , Stauss‐GraboM , HahnA . Significance of long‐chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children. European Journal of Paediatrics2010;169(2):149‐64. [DOI: 10.1007/s00431‐009‐1035‐8; PUBMED: 19672626 ] ">Schuchardt 2010</a>). Studies identified in <a href="./references#CD009398-bbs2-0039" title="GilliesD , SinnJKH , LadSS , LeachMJ , RossMJ . Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents. Cochrane Database of Systematic Reviews2012, Issue 7. [DOI: 10.1002/14651858.CD007986.pub2; Art. No.: CD007986.] ">Gillies 2012</a> and <a href="./references#CD009398-bbs2-0049" title="JamesS , MontgomeryP , WilliamsK . Omega‐3 fatty acids supplementation for autism spectrum disorders (ASD). Cochrane Database of Systematic Reviews2011, Issue 11. [DOI: 10.1002/14651858.CD007992.pub2; Art. No.: CD007992] ">James 2011</a> reviews on the use of PUFAs in children with neurodevelopmental problems used doses of PUFAs, given as omega‐3 alone or combined with omega‐6, ranging from 200 mg/d to 1500 mg/d. Outcome measures should focus on standardised tests for measuring learning abilities, such as reading, writing and mathematics skills, as well as adverse effects. On the basis of evidence required to reach a steady state, the intervention period should be longer than three months (at least four months to six months), although we have no clear evidence to guide us on the duration of the intervention required to bring about a measurable change in learning outcomes. </p> <p>When secondary outcomes (such as behaviour) are reported, we cannot be sure if they would directly affect learning ability, which is the main concern for children with specific learning disorders. If possible, care should be taken to hide the taste and smell of PUFAs, as the 'fishy' taste could potentially break the blinding process (<a href="./references#CD009398-bbs2-0060" title="MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. [DOI: 10.1001/jama.2010.1507; PUBMED: 20959577 ] ">Makrides 2010</a>). </p> <p>Further research is also needed to establish the most appropriate age for initiation of PUFAs. This is important because changes in the brain associated with specific learning disorders that might be modifiable by PUFAs may occur in very young children or even during foetal life (<a href="./references#CD009398-bbs2-0083" title="TaylorKE , RichardsonAJ . Visual function, fatty acids and dyslexia. Prostaglandin, Leukotrienes and Essential Fatty Acids2000;63(1‐2):89‐93. [DOI: 10.1054/plef.2000.0197; PUBMED: 10970719 ] ">Taylor 2000</a>). One of the challenges of conducting studies in younger children is the need for reliable early diagnostic tests. Hence, more studies are needed to develop such tests. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD009398-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD009398-sec-0015"></div> <div class="table" id="CD009398-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Summary of findings table</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>PUFAs vs placebo</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children with specific learning disorders<br/> <b>Setting:</b> community<br/> <b>Intervention:</b> PUFAs<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with PUFAs</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standardised tests of reading, writing, spelling or mathematics skills (overall)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>None of the included studies assessed effects on standardised tests of reading, writing, spelling or mathematics skills </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Adverse effect (gastrointestinal disturbance)<br/> Follow‐up: mean 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.43</b> <br/> (0.25 to 8.15) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>116<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>35 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>50 per 1000<br/> (9 to 286) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> CI: confidence interval; PUFAs: polyunsaturated fatty acids; RCTs: randomised controlled trials; RR: risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality.</b> We are very confident that the true effect lies close to that of the estimate of effect.<br/> <b>Moderate quality.</b> We are moderately confident in the effect estimate. The true effect is likely to be close to the estimate of effect but may be substantially different.<br/> <b>Low quality.</b> Our confidence in the effect estimate is limited. The true effect may be substantially different from the estimate of effect.<br/> <b>Very low quality.</b> We have very little confidence in the effect estimate. The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Small sample size with few events. Extremely wide CIs.<br/> <sup>b</sup>Selective outcome reporting in one study. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD009398-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD009398-sec-0016"></div> <section id="CD009398-sec-0017"> <h3 class="title" id="CD009398-sec-0017">Description of the condition</h3> <p>Specific learning disorders are a heterogenous group of disorders that can be broadly defined as unexpected, specific and persistent failure to acquire adequate academic skills despite conventional teaching, adequate intelligence and ample sociocultural opportunities (<a href="./references#CD009398-bbs2-0055" title="LagaeL . Learning disabilities: definitions, epidemiology, diagnosis, and intervention strategies. Pediatric Clinics of North America2008;55(6):1259‐68. [DOI: 10.1016/j.pcl.2008.08.001; PUBMED: 19041456 ] ">Lagae 2008</a>). These specific academic skills have been categorised as listening (receptive language), speaking (expressive language), basic reading, reading comprehension, written expression, mathematical calculation and mathematical reasoning (<a href="./references#CD009398-bbs2-0059" title="LyonsGR . Learning disabilities. The Future of Children1996;6(1):54‐74. [www.futureofchildren.org/publications/docs/06_01_03.pdf] ">Lyons 1996</a>). In general, about 5% of school children have a specific learning disorder (<a href="./references#CD009398-bbs2-0055" title="LagaeL . Learning disabilities: definitions, epidemiology, diagnosis, and intervention strategies. Pediatric Clinics of North America2008;55(6):1259‐68. [DOI: 10.1016/j.pcl.2008.08.001; PUBMED: 19041456 ] ">Lagae 2008</a>), 80% of which are reading disorders (<a href="./references#CD009398-bbs2-0075" title="ShaywitzSE . Current concepts: dyslexia. The New England Journal of Medicine1998;338(5):307‐12. [DOI: 10.1056/NEJM199801293380507] ">Shaywitz 1998</a>). </p> <p>The <i>Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition</i> (DSM‐5) (<a href="./references#CD009398-bbs2-0020" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth. (DSM‐5). Washingon DC: American Psychiatric Association, 2013. ">APA 2013</a>) and the <i>International Classification of Diseases, 10th Revision</i> (ICD‐10) (<a href="./references#CD009398-bbs2-0092" title="World Health Organization. The ICD‐10 Classification of Mental and Behavioural Disorders. Clinical Descriptions and Diagnostic Guidelines. Geneva: WHO, 1992. ">WHO 1992</a>) classify and describe specific learning disorders similarly. They point out two important characteristics. First, learning disorders are developmental disorders that begin in early childhood and do not result from inadequate opportunities for learning nor from the presence of physical abnormalities. Second, researchers have noted a discrepancy between expected achievement for the level of intelligence and actual achievement on individually administered, standardised tests of reading, writing and mathematics. </p> <p>Specific learning disorders present as a reading disorder (dyslexia), a writing disorder (dysgraphia), a mathematical skills disorder (dyscalculia) or a combination of any of the three. The specific learning disorder that occurs most often as an independent disorder is reading disorder, or dyslexia. Dyslexia affects between 5% and 17.5% of school‐aged children (<a href="./references#CD009398-bbs2-0075" title="ShaywitzSE . Current concepts: dyslexia. The New England Journal of Medicine1998;338(5):307‐12. [DOI: 10.1056/NEJM199801293380507] ">Shaywitz 1998</a>). The next most common disorder is dyscalculia, which affects between 3% and 6.5% of school‐aged children (<a href="./references#CD009398-bbs2-0074" title="ShalevRS . Developmental dyscalculia. Journal of Child Neurology2004;19(10):765‐71. [DOI: 10.1177/08830738040190100601; PUBMED: 15559892] ">Shalev 2004</a>). Other types of specific learning disorders, such as difficulties with writing or spelling, are usually accompanied by a reading disorder (<a href="./references#CD009398-bbs2-0019" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth. Text Revision (DSM‐IV‐TR). Washington DC: American Psychiatric Association, 2000. ">APA 2000</a>; <a href="./references#CD009398-bbs2-0034" title="DirksE , SpyerG , vanLieshoutECDM , deSonnevilleL . Prevalence of combined reading and arithmetic disabilities. Journal of Learning Disabilities2008;41(5):460‐73. [DOI: 10.1177/0022219408321128; PUBMED: 18768777 ] ">Dirks 2008</a>). It is not unusual for individuals with a specific learning disorder to have other coexistent neurodevelopmental problems such as attention deficit hyperactivity disorder (ADHD), developmental co‐ordination disorder, conduct disorder, oppositional defiant disorder, major depressive disorder and dysthymic disorder (<a href="./references#CD009398-bbs2-0019" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth. Text Revision (DSM‐IV‐TR). Washington DC: American Psychiatric Association, 2000. ">APA 2000</a>). A recent review found that up to 45% of children have a specific learning disorder coexisting with ADHD (<a href="./references#CD009398-bbs2-0037" title="DuPaulGJ , GormleyMJ , LaracySD . Comorbidity of LD and ADHD: implications of DSM‐5 for assessment and treatment. Journal of Learning Disabilities2013;46(1):43‐51. [DOI: 10.1177/0022219412464351; PUBMED: 23144063] ">DuPaul 2013</a>). DSM‐5 provides a more inclusive definition and states that it is no longer necessary to divide specific learning disorders into the categories above (<a href="./references#CD009398-bbs2-0020" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth. (DSM‐5). Washingon DC: American Psychiatric Association, 2013. ">APA 2013</a>). </p> <p>Researchers who assess learning outcomes or academic achievement in children with specific learning disorders should measure the component skills of reading, spelling and mathematics by administering various achievement tests (<a href="./references#CD009398-bbs2-0024" title="BeitchmanJH , YoungAR . Learning disorders with special emphasis on reading disorders: a review of the past 10 years. Journal of the American Academy of Child and Adolescent Psychiatry1997;36(8):1020‐32. [DOI: 10.1097/00004583‐199708000‐00009; PUBMED: 9256582] ">Beitchman 1997</a>). Tests of reading should assess accuracy, fluency and comprehension (<a href="./references#CD009398-bbs2-0024" title="BeitchmanJH , YoungAR . Learning disorders with special emphasis on reading disorders: a review of the past 10 years. Journal of the American Academy of Child and Adolescent Psychiatry1997;36(8):1020‐32. [DOI: 10.1097/00004583‐199708000‐00009; PUBMED: 9256582] ">Beitchman 1997</a>), and tests of mathematics should assess numerical concepts, number facts and arithmetic procedures (<a href="./references#CD009398-bbs2-0074" title="ShalevRS . Developmental dyscalculia. Journal of Child Neurology2004;19(10):765‐71. [DOI: 10.1177/08830738040190100601; PUBMED: 15559892] ">Shalev 2004</a>). Writing is sometimes assessed as spelling (<a href="./references#CD009398-bbs2-0018" title="AngelelliP , JudicaA , SpinelliD , ZoccolottiP , LuzzattiC . Characteristics of writing disorders in Italian dyslexic children. Cognitive and Behavioral Neurology2004;17(1):18‐31. [PUBMED: 15209222] ">Angelelli 2004</a>), but specific tests are also available to assess handwriting. These assessments are best done by means of standardised tests, namely, tests that can be conducted under exact and repeatable conditions and yield scores that can be interpreted uniformly (<a href="./references#CD009398-bbs2-0035" title="DominoG , DominoML . Psychological Testing. An Introduction. 2nd Edition. New York: Cambridge University Press, 2006. ">Domino 2006</a>). </p> <p>Children with specific learning disorders may have poor academic achievement, as well as problems with self‐esteem (<a href="./references#CD009398-bbs2-0084" title="TerrasM , ThompsonL , MinnisH . Dyslexia and psycho‐social functioning: an exploratory study of the role of self‐esteem and understanding. Dyslexia2009;15(4):304‐27. [DOI: 10.1002/dys.386; PUBMED: 19384920] ">Terras 2009</a>) and school failure (<a href="./references#CD009398-bbs2-0055" title="LagaeL . Learning disabilities: definitions, epidemiology, diagnosis, and intervention strategies. Pediatric Clinics of North America2008;55(6):1259‐68. [DOI: 10.1016/j.pcl.2008.08.001; PUBMED: 19041456 ] ">Lagae 2008</a>). In the United States in 2006, about 25% of school‐aged children and adolescents with specific learning disorders failed to complete school (<a href="./references#CD009398-bbs2-0085" title="US Department of Education, Office of Special Education and Rehabilitative Services, Office of Special Education Programs. 30th Annual Report to Congress on the Implementation of the Individuals with Disabilities Education Act, 2008. www2.ed.gov/about/reports/annual/osep/2008/parts‐b‐c/index.html (accessed 8 October 2015). ">USDE 2011</a>). </p> </section> <section id="CD009398-sec-0018"> <h3 class="title" id="CD009398-sec-0018">Description of the intervention</h3> <p>Polyunsaturated fatty acids (PUFAs) are essential fatty acids that must be obtained through the diet because the human body is incapable of producing them (<a href="./references#CD009398-bbs2-0048" title="InnisSM . Dietary omega 3 fatty acids and the developing brain. Brain Research2008;1237:35‐43. [DOI: 10.1016/j.brainres.2008.08.078; PUBMED: 18789910 ] ">Innis 2008</a>). Polyunsaturated fatty acids are classified according to the position of double bonds from the methyl end of the molecule. The main classes of PUFAs studied in children with neurodevelopmental problems are omega‐3 and omega‐6 fatty acids (<a href="./references#CD009398-bbs2-0073" title="SchuchardtJP , HussM , Stauss‐GraboM , HahnA . Significance of long‐chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children. European Journal of Paediatrics2010;169(2):149‐64. [DOI: 10.1007/s00431‐009‐1035‐8; PUBMED: 19672626 ] ">Schuchardt 2010</a>). Little is known about the use of other PUFAs, such as omega‐9 (oleic acid), in these children. </p> <p>The omega‐3 fatty acids include alpha‐linolenic acid (ALA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (<a href="./references#CD009398-bbs2-0076" title="SimopoulosAP . Omega‐3 fatty acids in health and disease and in growth and development. The American Journal of Clinical Nutrition1991;54(3):438‐63. [PUBMED: 1908631] ">Simopoulos 1991</a>). Among these, DHA is most abundantly found in the human central nervous system and is concentrated in the membrane lipids of cerebral gray matter and in the retina (<a href="./references#CD009398-bbs2-0048" title="InnisSM . Dietary omega 3 fatty acids and the developing brain. Brain Research2008;1237:35‐43. [DOI: 10.1016/j.brainres.2008.08.078; PUBMED: 18789910 ] ">Innis 2008</a>). Omega‐6 fatty acids comprise linoleic acid (LA), gamma‐linolenic acid (GLA) and arachidonic acid (AA) (<a href="./references#CD009398-bbs2-0076" title="SimopoulosAP . Omega‐3 fatty acids in health and disease and in growth and development. The American Journal of Clinical Nutrition1991;54(3):438‐63. [PUBMED: 1908631] ">Simopoulos 1991</a>). Common dietary sources of omega‐3 fatty acids are oily fish (<a href="./references#CD009398-bbs2-0091" title="WhelanJ , JahnsL , KavanaghK . Docosahexaenoic acid: measurements in food and dietary exposure. Prostaglandins, Leukotrienes and Essential Fatty Acids2009;81(2‐3):133‐6. [DOI: 10.1016/j.plefa.2009.05.008; PUBMED: 19493663 ] ">Whelan 2009</a>), and omega‐6 fatty acids are commonly found in grains such as wheat, rice and maize (<a href="./references#CD009398-bbs2-0076" title="SimopoulosAP . Omega‐3 fatty acids in health and disease and in growth and development. The American Journal of Clinical Nutrition1991;54(3):438‐63. [PUBMED: 1908631] ">Simopoulos 1991</a>). Alternative sources of omega‐3 fatty acids include marine microbiota and transgenic oilseeds (<a href="./references#CD009398-bbs2-0071" title="SayanovaO , NapierJA . Transgenic oilseed crops as an alternative to ﬁsh oils. Prostaglandins, Leukotrienes and Essential Fatty Acids2011;85(5):253‐60. [DOI: 10.1016/j.plefa.2011.04.013; PUBMED: 21596549 ] ">Sayanova 2011</a>). </p> <p>Conversion of the omega‐3 fatty acid precursor ALA to EPA and DHA requires the same enzyme as is required for conversion of the omega‐6 fatty acid precursor LA to GLA and AA. Therefore, an increase in the supply of LA will lead to competitive reduction in production of EPA and DHA (<a href="./references#CD009398-bbs2-0073" title="SchuchardtJP , HussM , Stauss‐GraboM , HahnA . Significance of long‐chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children. European Journal of Paediatrics2010;169(2):149‐64. [DOI: 10.1007/s00431‐009‐1035‐8; PUBMED: 19672626 ] ">Schuchardt 2010</a>). The importance of this competition is that both AA (omega‐6) and EPA (omega‐3) are parent derivatives of eicosanoids, but they have different physiological functions (<a href="./references#CD009398-bbs2-0077" title="SimopoulosAP . The importance of the ratio of omega‐6/omega‐3 essential fatty acids. Biomedicine &amp; Pharmacotherapy2002;56(8):365–79. [DOI: 10.1016/S0753‐3322(02)00253‐6; PUBMED: 12442909] ">Simopoulos 2002</a>). The ideal omega‐6/omega‐3 ratio is 1:1 to 4:1, but ratios in the modern diet may be as high as 20:1 (<a href="./references#CD009398-bbs2-0077" title="SimopoulosAP . The importance of the ratio of omega‐6/omega‐3 essential fatty acids. Biomedicine &amp; Pharmacotherapy2002;56(8):365–79. [DOI: 10.1016/S0753‐3322(02)00253‐6; PUBMED: 12442909] ">Simopoulos 2002</a>). The ratio of omega‐6 to omega‐3 fatty acids is thus important, and abnormalities in this ratio are seen in adults with dyslexia (<a href="./references#CD009398-bbs2-0032" title="CyhlarovaE , BellJG , DickJR , MacKinlayEE , SteinJF , RichardsonAJ . Membrane fatty acids, reading and spelling in dyslexic and non‐dyslexic adults. European Neuropsychopharmacology2007;17(2):116‐21. [DOI: 10.1016/j.euroneuro.2006.07.003; PUBMED: 16997534 ] ">Cyhlarova 2007</a>; <a href="./references#CD009398-bbs2-0054" title="LaasonenM , HokkanenL , LeppämäkiS , TaniP , ErkkiläAT . Project DyAdd: fatty acids in adult dyslexia, ADHD, and their comorbid combination. Prostaglandins, Leukotrienes, and Essential Fatty Acids2009;81(1):89‐96. [DOI: 10.1016/j.plefa.2009.04.005; PUBMED: 19523794] ">Laasonen 2009</a>) and in children with ADHD and learning disabilities (<a href="./references#CD009398-bbs2-0063" title="MilteCM , SinnN , BuckleyJD , CoatesAM , YoungRM , HowePR . Polyunsaturated fatty acids, cognition and literacy in children with ADHD with and without learning difficulties. Journal of Child Health Care2011;15(4):299‐311. [DOI: 10.1177/1367493511403953; PUBMED: 21828168 ] ">Milte 2011</a>). </p> <p>Polyunsaturated fatty acid supplements are given as omega‐3 fatty acids alone (<a href="./references#CD009398-bbs2-0009" title="RichardsonAJ , MontgomeryP . The Oxford‐Durham Study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Paediatrics2005;115(5):1360‐6. [DOI: 10.1542/peds.2004‐2164; PUBMED: 15867048] ">Richardson 2005</a>), or as omega‐3 fatty acids in combination with omega‐6 fatty acids (<a href="./references#CD009398-bbs2-0001" title="JohnsonM , ÖstlundS , FranssonG , KadesjöB , GillbergC . Omega‐3/omega‐6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo‐controlled trial in children and adolescents. Journal of Attention Disorders2009;12(5):394‐401. [DOI: 10.1177/1087054708316261; PUBMED: 18448859] ">Johnson 2009</a>). Most PUFA supplements contain some vitamin E (usually 0.6 mg of alpha‐tocopherol to 1 gram PUFA) to prevent oxidation of PUFAs in tissues (<a href="./references#CD009398-bbs2-0088" title="ValkEE , HornstraG . Relationship between vitamin E requirement and polyunsaturated fatty acid intake in man: a review. International Journal for Vitamin and Nutrition Research2000;70(2):31‐42. [DOI: 10.1024/0300‐9831.70.2.31; PUBMED: 10804454 ] ">Valk 2000</a>). The duration of PUFA supplementation is an important factor. Kinetic studies show that it takes about four to six months for DHA to achieve a steady state in red blood cell membranes (<a href="./references#CD009398-bbs2-0021" title="ArterburnLM , HallEB , OkenH . Distribution, interconversion, and dose response of n‐3 fatty acids in humans. The American Journal of Clinical Nutrition2006;83(6 Suppl):1467S‐76S. [PUBMED: 16841856] ">Arterburn 2006</a>). Therefore, any duration of intervention less than three months is likely to be ineffective. </p> </section> <section id="CD009398-sec-0019"> <h3 class="title" id="CD009398-sec-0019">How the intervention might work</h3> <p>Polyunsaturated fatty acids have two major functions in the central nervous system: maintaining the fluidity of the cell membrane and sustaining the integrity of the myelin sheath (<a href="./references#CD009398-bbs2-0094" title="YehudaS , RabinovitzS , MostofskyDI . Essential fatty acids and the brain: from infancy to aging. Neurobiology of Aging2005;26(1 Suppl):92‐102. [DOI: 10.1016/j.neurobiolaging.2005.09.013; PUBMED: 16226347 ] ">Yehuda 2005</a>). Neuronal cell membrane fluidity is necessary for exchange of neuronal information. Both ALA (omega‐3) and LA (omega‐6) can directly increase the fluidity index of the cell membrane (<a href="./references#CD009398-bbs2-0094" title="YehudaS , RabinovitzS , MostofskyDI . Essential fatty acids and the brain: from infancy to aging. Neurobiology of Aging2005;26(1 Suppl):92‐102. [DOI: 10.1016/j.neurobiolaging.2005.09.013; PUBMED: 16226347 ] ">Yehuda 2005</a>). Deficiency in omega‐3 fatty acids, especially during the early years of development, can result in delayed myelination of neurons and may manifest as learning, motor, visual and auditory abnormalities (<a href="./references#CD009398-bbs2-0094" title="YehudaS , RabinovitzS , MostofskyDI . Essential fatty acids and the brain: from infancy to aging. Neurobiology of Aging2005;26(1 Suppl):92‐102. [DOI: 10.1016/j.neurobiolaging.2005.09.013; PUBMED: 16226347 ] ">Yehuda 2005</a>). In an animal study model, the addition of an omega‐6‐rich diet reversed the learning disability of omega‐3‐deficient rats (<a href="./references#CD009398-bbs2-0047" title="IkemotoA , OhishiM , SatoY , HataN , MisawaY , FujiiY , et al. Reversibility of n‐3 fatty acid deficiency‐induced alterations of learning behavior in the rat: level of n‐6 fatty acids as another critical factor. Journal of Lipid Research2001;42(10):1655‐63. [PUBMED: 11590222] ">Ikemoto 2001</a>). </p> <p>Children with neurodevelopmental disorders, such as dyslexia, dyspraxia, ADHD and autism, have a higher incidence of omega‐3 fatty acid deficiency and imbalance of omega‐3 and omega‐6 fatty acids (<a href="./references#CD009398-bbs2-0067" title="RichardsonAJ , RossMA . Fatty acid metabolism in neurodevelopmental disorder: a new perspective on associations between attention‐deficit/hyperactivity disorder, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins, Leukotrienes and Essential Fatty Acids2000;63(1‐2):1‐9. [DOI: 10.1054/plef.2000.0184; PUBMED: 10970706 ] ">Richardson 2000a</a>). The earliest suggestion that children with a specific learning disorder may have an imbalance or deficiency in fatty acids came in a case report in 1985 (<a href="./references#CD009398-bbs2-0061" title="McDonald BakerS . A biochemical approach to the problem of dyslexia. Journal of Learning Disabilities1985;18(10):581‐4. [DOI: 10.1177/002221948501801003; PUBMED: 4086934] ">McDonald Baker 1985</a>). Subsequently, two studies demonstrated that individuals with dyslexia were more likely to have fatty acid deficiency signs (FADS), which include excessive thirst, frequent urination, dry skin, dry hair, brittle nails, dandruff and follicular keratosis (<a href="./references#CD009398-bbs2-0068" title="RichardsonAJ , CalvinCM , ClisbyC , SchoenheimerDR , MontgomeryP , HallJA , et al. Fatty acid deficiency signs predict the severity of reading and related difficulties in dyslexic children. Prostaglandins, Leukotrienes and Essential Fatty Acids2000;63(1‐2):69‐74. [DOI: 10.1054/plef.2000.0194; PUBMED: 10970716 ] ">Richardson 2000b</a>; <a href="./references#CD009398-bbs2-0080" title="StevensLJ , ZentallSS , AbateML , KuczekT , BurgessJR . Omega‐3 fatty acids in boys with behavior, learning, and health problems. Physiology &amp; Behavior1996;59(4‐5):915‐20. [DOI: 10.1016/0031‐9384(95)02207‐4; PUBMED: 8778886] ">Stevens 1996</a>). However, to date, no studies have specifically compared omega‐3 fatty acid levels in children with a specific learning disorder versus those in the general population. One study measuring cheek cell omega‐3 fatty acid levels in children attending mainstream school found no correlation of omega‐3 fatty acid level with reading or spelling abilities (<a href="./references#CD009398-bbs2-0053" title="KirbyA , WoodwardA , JacksonS , WangY , CrawfordMA . Childrens’ learning and behaviour and the association with cheek cell polyunsaturated fatty acid levels. Research in Developmental Disabilities2010;31(3):731‐42. [DOI: 10.1016/j.ridd.2010.01.015; PUBMED: 20172688 ] ">Kirby 2010</a>). Another randomised controlled trial (RCT) showed a significant improvement in the reading ability of children with developmental co‐ordination disorder whose diet was supplemented with omega‐3 fatty acids (<a href="./references#CD009398-bbs2-0009" title="RichardsonAJ , MontgomeryP . The Oxford‐Durham Study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Paediatrics2005;115(5):1360‐6. [DOI: 10.1542/peds.2004‐2164; PUBMED: 15867048] ">Richardson 2005</a>). </p> <p>The exact mechanism by which PUFAs may work in children with specific learning disorders remains unknown. Most available evidence pertains to reading disorders only. Below, we present three possible explanations of how supplementation of PUFAs may help children with a specific reading disorder. </p> <section id="CD009398-sec-0020"> <h4 class="title">Improving the visual magnocellular pathway</h4> <p>The visual neural pathway responsible for transmitting signals from the retina to the brain can be divided into large, heavily myelinated cells ‐ the magnocellular pathway ‐ and smaller cells ‐ the parvocellular pathway (<a href="./references#CD009398-bbs2-0078" title="SteinJ , WalshV . To see but not to read; the magnocellular theory of dyslexia. Trends in Neurosciences1997;20(4):147‐52. [DOI: 10.1016/S0166‐2236(96)01005‐3; PUBMED: 9106353] ">Stein 1997</a>). The magnocellular pathway is responsible for visual motion sensitivity, which is strongly related to reading ability (<a href="./references#CD009398-bbs2-0079" title="SteinJ . The neurobiology of reading difficulties. Prostaglandins, Leukotrienes and Essential Fatty Acids2000;63(1‐2):109‐16. [DOI: 10.1054/plef.2000.0200] ">Stein 2000</a>). Dyslexic individuals have been found to have poor motion sensitivity and abnormalities in binocular stability, both of which are linked to the visual magnocellular pathway (<a href="./references#CD009398-bbs2-0079" title="SteinJ . The neurobiology of reading difficulties. Prostaglandins, Leukotrienes and Essential Fatty Acids2000;63(1‐2):109‐16. [DOI: 10.1054/plef.2000.0200] ">Stein 2000</a>). The role of PUFAs in specific reading disorders or dyslexia may be linked to both early development of the magnocellular pathway (<a href="./references#CD009398-bbs2-0083" title="TaylorKE , RichardsonAJ . Visual function, fatty acids and dyslexia. Prostaglandin, Leukotrienes and Essential Fatty Acids2000;63(1‐2):89‐93. [DOI: 10.1054/plef.2000.0197; PUBMED: 10970719 ] ">Taylor 2000</a>) and its dysfunction (<a href="./references#CD009398-bbs2-0079" title="SteinJ . The neurobiology of reading difficulties. Prostaglandins, Leukotrienes and Essential Fatty Acids2000;63(1‐2):109‐16. [DOI: 10.1054/plef.2000.0200] ">Stein 2000</a>). </p> </section> <section id="CD009398-sec-0021"> <h4 class="title">Improving working memory</h4> <p>In animal studies, rats raised with a diet deficient in omega‐3 fatty acids were found to have poorer reference and working memory (<a href="./references#CD009398-bbs2-0030" title="ChungWL , ChenJJ , SuHM . Fish oil supplementation of control and (n‐3) fatty acid‐deficient male rats enhances reference and working memory performance and increases brain regional docosahexaenoic acid levels. The Journal of Nutrition2008;138(6):1165‐71. [PUBMED: 18492851] ">Chung 2008</a>). Children with specific learning disorders ‐ reading or mathematics disorder alone or in combination (<a href="./references#CD009398-bbs2-0038" title="GearyDC . Consequences, characteristics, and causes of mathematical learning disabilities and persistent low achievement in mathematics. Journal of Developmental and Behavioral Pediatrics2011;32(3):250‐63. [DOI: 10.1097/DBP.0b013e318209edef; PMC3131082 ; PUBMED: 21285895] ">Geary 2011</a>; <a href="./references#CD009398-bbs2-0072" title="SchuchardtK , MaehlerC , HasselhornM . Working memory deficits in children with specific learning disorders. Journal of Learning Disabilities2008;41(6):514‐23. [DOI: 10.1177/0022219408317856; PUBMED: 18625783 ] ">Schuchardt 2008</a>) ‐ also have impairments in their working memory. Therefore, PUFA supplementation could help to improve their learning abilities. </p> </section> <section id="CD009398-sec-0022"> <h4 class="title">Improving dark adaptation</h4> <p>Vision in low light is regulated mainly by rod cells in the retina, which are rich in omega‐3 fatty acids, in particular, DHA (<a href="./references#CD009398-bbs2-0048" title="InnisSM . Dietary omega 3 fatty acids and the developing brain. Brain Research2008;1237:35‐43. [DOI: 10.1016/j.brainres.2008.08.078; PUBMED: 18789910 ] ">Innis 2008</a>). Poor dark adaptation or reduced scotopic sensitivity has been associated with dyslexia, although not consistently (<a href="./references#CD009398-bbs2-0028" title="CarrollTA , MullaneyP , EustaceP . Dark adaptation in disabled readers screened for scotopic sensitivity syndrome. Perceptual and Motor Skills1994;78(1):131‐41. [DOI: 10.2466/pms.1994.78.1.131; PUBMED: 8177650 ] ">Carroll 1994</a>; <a href="./references#CD009398-bbs2-0040" title="GreatrexJ C , DrasdoN , DresserK . Scotopic sensitivity in dyslexia and requirements for DHA supplementation. The Lancet2000;355(9213):1429‐30. [PUBMED: 10791530] ">Greatrex 2000</a>). If such an association is substantiated, this adds to the biological plausibility of why omega‐3 might be involved in dyslexia. In a small study of a group of dyslexic individuals, supplementation with DHA‐rich fish oil improved their dark adaptation (<a href="./references#CD009398-bbs2-0081" title="StordyBJ . Dark adaptation, motor skills, docosahexaenoic acid, and dyslexia. The American Journal of Clinical Nutrition2000;71(1 Suppl):323S‐6S. [PUBMED: 10617990] ">Stordy 2000</a>). </p> </section> <section id="CD009398-sec-0023"> <h4 class="title">Safety concerns of PUFA supplementation</h4> <p>Researchers have expressed two major concerns regarding PUFA supplements. The first arises from the sources of PUFAs, especially omega‐3 fatty acids, which often are derived from oily fish. Concerns surround consumption of oily fish and toxic environmental contamination from mercury, polychlorinated biphenyls (PCBs) and dioxin (<a href="./references#CD009398-bbs2-0023" title="BaysHE . Safety considerations with omega‐3 fatty acid therapy. The American Journal of Cardiology2007;99(6A):35C‐43C. [DOI: 10.1016/j.amjcard.2006.11.020; PUBMED: 17368277 ] ">Bays 2007</a>; <a href="./references#CD009398-bbs2-0086" title="U.S.Food , DrugAdministration . Mercury in fish: cause for concern?. www.fda.gov/OHRMS/DOCKETS/ac/02/briefing/3872_Advisory%207.pdf?utm_campaign=Google2&amp;utm_source=fdaSearch&amp;utm_medium=website&amp;utm_term=mercury in fish&amp;utm_content=6 (accessed 31 January 2011). ">USFDA 1995</a>). Strict adherence to good manufacturing guidelines is the key factor in the production of omega‐3 fatty acid supplements that are free from these contaminants (<a href="./references#CD009398-bbs2-0023" title="BaysHE . Safety considerations with omega‐3 fatty acid therapy. The American Journal of Cardiology2007;99(6A):35C‐43C. [DOI: 10.1016/j.amjcard.2006.11.020; PUBMED: 17368277 ] ">Bays 2007</a>). The second concern involves adverse effects resulting directly from omega‐3 fatty acids, specifically, increased risk of bleeding and reduced immunity (<a href="./references#CD009398-bbs2-0087" title="U.S.Food , DrugAdministration . Center for Food Safety and Applied Nutrition. Letter regarding dietary supplement health claim for omega‐3 fatty acids and coronary heart disease. (Docket No 91N‐0103). www.fda.gov/ohrms/dockets/DOCKETS/95s0316/95s‐0316‐Rpt0272‐38‐Appendix‐D‐Reference‐F‐FDA‐vol205.pdf?utm_campaign=Google2&amp;utm_source=fdaSearch&amp;utm_medium=website&amp;utm_term=Letter regarding dietary supplement health claim for omega‐3 fatty acids and coronary heart disease&amp;utm_content=1 (accessed 28 January 2011). ">USFDA 2000</a>). High doses of omega‐3 fatty acids are thought to impair platelet aggregation and reduce the individual's immune response (<a href="./references#CD009398-bbs2-0056" title="LienEL . Toxicology and safety of DHA. Prostaglandins, Leukotrienes and Essential Fatty Acids2009;81(2‐3):125‐32. [DOI: 10.1016/j.plefa.2009.05.004; PUBMED: 19501496] ">Lien 2009</a>). However, a review of preclinical toxicology studies and intervention studies showed that omega‐3 fatty acid supplementation is generally safe (<a href="./references#CD009398-bbs2-0056" title="LienEL . Toxicology and safety of DHA. Prostaglandins, Leukotrienes and Essential Fatty Acids2009;81(2‐3):125‐32. [DOI: 10.1016/j.plefa.2009.05.004; PUBMED: 19501496] ">Lien 2009</a>). A narrative review on the safety of PUFAs in high‐risk individuals taking up to three grams of PUFAs per day did not show increased risk of bleeding (<a href="./references#CD009398-bbs2-0042" title="HamazakiT , ColleranH , HamazakiK , MatsuokaY , ItomuraM , HibbelnJ . The safety of fish oils for those whose risk of injury is high. Military Medicine2014;179(11 Suppl):134‐7. [DOI: 10.7205/MILMED‐D‐14‐00157; PUBMED: 25373097 ] ">Hamazaki 2014</a>). Other minor adverse effects include hypersensitivity to fish or seafood and gastrointestinal disturbances (<a href="./references#CD009398-bbs2-0016" title="AbramowiczM , ZuccottiG , PflommJ‐M . Fish oil supplements. JAMA2014;312(8):839‐40. [DOI: 10.1001/jama.2014.9758; PUBMED: 25157728 ] ">Abramowicz 2014</a>; <a href="./references#CD009398-bbs2-0065" title="PresterL . Seafood allergy, toxicity, and intolerance: a review. Journal of the American College of Nutrition2016;35(3):271‐83. [DOI: 10.1080/07315724.2015.1014120; PUBMED: 26252073 ] ">Prester 2016</a>). </p> </section> </section> <section id="CD009398-sec-0024"> <h3 class="title" id="CD009398-sec-0024">Why it is important to do this review</h3> <p>The shift in the burden of health care for children from acute, life‐threatening problems to chronic, non‐communicable diseases has resulted in increased recognition of specific learning disorders (<a href="./references#CD009398-bbs2-0057" title="LiuL , JohnsonHL , CousensS , PerinJ , ScottS , LawnJE , et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet2012;379(9832):2151‐61. [DOI: 10.1016/S0140‐6736(12)60560‐1; PUBMED: 22579125] ">Liu 2012</a>; <a href="./references#CD009398-bbs2-0058" title="LopezAD , MathersCD , EzzatiM , JamisonDT , MurrayCJ . Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet2006;367(9524):1747‐57. [DOI: 10.1016/S0140‐6736(06)68770‐9] ">Lopez 2006</a>). At present, the mainstay of treatment for a child with a specific learning disorder is educational intervention because learning disorders are viewed essentially as language‐based disorders (<a href="./references#CD009398-bbs2-0044" title="HandlerSM , FiersonWM , Section on Ophthalmology and Council on Children with Disabilities, American Academy ofOphthalmology , American Association for Pediatric Ophthalmology and Strabismus, American Association of Certified Orthoptists. Joint Technical Report ‐ Learning disabilities, dyslexia, and vision. Pediatrics2011;127(3):e818‐e56. [DOI: 10.1542/peds.2010‐3670; PUBMED: 21357342] ">Handler 2011</a>). To be effective, educational interventions require long‐term commitment from the child and his or her family (<a href="./references#CD009398-bbs2-0017" title="AlexanderAW , Slinger‐ConstantAM . Current status of treatments for dyslexia: critical review. Journal of Child Neurology2004;19(10):744‐58. [PUBMED: 15559890] ">Alexander 2004</a>). During childhood, intervention is focused on remediation, but in adulthood, intervention is targeted at adjustment and compensation strategies (<a href="./references#CD009398-bbs2-0055" title="LagaeL . Learning disabilities: definitions, epidemiology, diagnosis, and intervention strategies. Pediatric Clinics of North America2008;55(6):1259‐68. [DOI: 10.1016/j.pcl.2008.08.001; PUBMED: 19041456 ] ">Lagae 2008</a>). Therefore, it is not surprising that individuals with this disability and their families look for unconventional methods of treatment, such as visual training, optometric exercise, tinted glasses and cerebellar exercises (<a href="./references#CD009398-bbs2-0055" title="LagaeL . Learning disabilities: definitions, epidemiology, diagnosis, and intervention strategies. Pediatric Clinics of North America2008;55(6):1259‐68. [DOI: 10.1016/j.pcl.2008.08.001; PUBMED: 19041456 ] ">Lagae 2008</a>). Most of these methods are costly and have not been scientifically proven (<a href="./references#CD009398-bbs2-0064" title="Editorial: a cure for dyslexia?. Nature Neuroscience2007; Vol. 10, issue 2:135. [DOI: 10.1038/nn0207‐135] ">NPG 2007</a>). </p> <p>Nutritional supplementation is a popular alternative treatment because of its ease of administration, relative safety, availability and affordability. Two Cochrane systematic reviews recently examined the use of PUFAs in children with ADHD (<a href="./references#CD009398-bbs2-0039" title="GilliesD , SinnJKH , LadSS , LeachMJ , RossMJ . Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents. Cochrane Database of Systematic Reviews2012, Issue 7. [DOI: 10.1002/14651858.CD007986.pub2; Art. No.: CD007986.] ">Gillies 2012</a>) and autism spectrum disorders (<a href="./references#CD009398-bbs2-0049" title="JamesS , MontgomeryP , WilliamsK . Omega‐3 fatty acids supplementation for autism spectrum disorders (ASD). Cochrane Database of Systematic Reviews2011, Issue 11. [DOI: 10.1002/14651858.CD007992.pub2; Art. No.: CD007992] ">James 2011</a>). Review authors concluded that little or no evidence indicates that PUFAs are beneficial for children with ADHD or autism. This review will add to our understanding of the potential therapeutic role of PUFAs. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD009398-sec-0025" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD009398-sec-0025"></div> <p> <ol id="CD009398-list-0001"> <li> <p>To assess effects on learning outcomes of supplementation of polyunsaturated fatty acids (PUFAs) for children with specific learning disorders. </p> </li> <li> <p>To determine whether adverse effects of supplementation of PUFAs are reported in these children. </p> </li> </ol> </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD009398-sec-0026" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD009398-sec-0026"></div> <section id="CD009398-sec-0027"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD009398-sec-0028"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCTs) or quasi‐RCTs.</p> </section> <section id="CD009398-sec-0029"> <h4 class="title">Types of participants</h4> <p>Children under 18 years of age with specific learning disorders, as diagnosed according to the <i>Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition</i> (DSM‐5) (<a href="./references#CD009398-bbs2-0020" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth. (DSM‐5). Washingon DC: American Psychiatric Association, 2013. ">APA 2013</a>) or earlier editions; the <i>International Classification of Diseases, 10th Revision</i> (ICD‐10) (<a href="./references#CD009398-bbs2-0092" title="World Health Organization. The ICD‐10 Classification of Mental and Behavioural Disorders. Clinical Descriptions and Diagnostic Guidelines. Geneva: WHO, 1992. ">WHO 1992</a>) or earlier revisions; or similar criteria. Specific learning disorders may include: </p> <p> <ol id="CD009398-list-0002"> <li> <p>reading disorder (developmental dyslexia);</p> </li> <li> <p>mathematics disorder (developmental dyscalculia);</p> </li> <li> <p>writing disorder (dysgraphia); and</p> </li> <li> <p>spelling disorder.</p> </li> </ol> </p> <p>The specific learning disorder may occur in conjunction with other neurodevelopmental disorders such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorders (ASDs). </p> </section> <section id="CD009398-sec-0030"> <h4 class="title">Types of interventions</h4> <p>Polyunsaturated fatty acids (PUFAs) compared with placebo or no treatment. Any other nutritional supplements and educational interventions could have been used but must have been given to both intervention and control groups. </p> <p>('Nutritional supplements' refers to interventions that may directly affect the outcome and does not include antioxidants, such as vitamin E, added to PUFA supplements for the purpose of preventing oxidation.) </p> </section> <section id="CD009398-sec-0031"> <h4 class="title">Types of outcome measures</h4> <section id="CD009398-sec-0032"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD009398-list-0003"> <li> <p>Reading, writing, spelling or mathematics scores measured by standardised tests such as: </p> <ol id="CD009398-list-0004"> <li> <p>Weschsler Objective Reading Dimensions (<a href="./references#CD009398-bbs2-0090" title="WechslerD . Wechsler Objective Reading Dimensions (WORD). www.psychometrics.cam.ac.uk/services/psychometric‐tests/wold (accessed 1 September 2016). ">Weschler 1993</a>); </p> </li> <li> <p>Woodcock Reading Mastery Tests (<a href="./references#CD009398-bbs2-0093" title="WoodcockRW . Woodcock Reading Mastery Tests, Third Edition (WRMT™‐III). www.pearsonclinical.com/education/products/100000264/woodcock‐reading‐mastery‐tests‐third‐edition‐wrmt‐iii.html (accessed 1 September 2016). ">Woodcock 2011</a>); </p> </li> <li> <p>Gray Oral Reading Test (<a href="./references#CD009398-bbs2-0027" title="WiederholtJL , BryantBR . Gray Oral Reading Test‐Fifth Edition (GORT‐5). www.pearsonclinical.com/language/products/100000106/gray‐oral‐reading‐test‐fifth‐edition‐gort‐5.html (accessed 1 September 2016). ">Bryant 2011</a>); </p> </li> <li> <p>Wide Range Achievement Test (<a href="./references#CD009398-bbs2-0070" title="WilkinsonGS , RobertsonGJ . Wide Range Achievement Test 4 (WRAT4). www.pearsonclinical.com/education/products/100001722/wide‐range‐achievement‐test‐4‐‐wrat4.html (accessed 1 September 2016). ">Robertson 2006</a>); </p> </li> <li> <p>Young's Group Mathematics Test (<a href="./references#CD009398-bbs2-0095" title="YoungD . Group Mathematics Test Manual. 3rd Edition. https://www.hoddereducation.co.uk/Product?Product=9780340116203#! (accessed 1 September 2016). ">Young 1996</a>); </p> </li> <li> <p>Neuropsychological Test Battery for Number Processing and Calculation in Children (<a href="./references#CD009398-bbs2-0089" title="vonAsterMG , BzufkaMW , HornRR . Neuropsychological Test Battery for Number Processing and Arithmetic in Children ‐ Kindergarten version [ZAREKI‐K. Neuropsychologische Testbatterie für Zahlenverarbeitung und Rechnen bei Kindern ‐ Kindergartenversion]. www.testzentrale.de/shop/neuropsychologische‐testbatterie‐fuer‐zahlenverarbeitung‐und‐rechnen‐bei‐kindern‐kindergartenversion.html (accessed 1 September 2016). ">von Aster 2006</a>); </p> </li> <li> <p>British Ability Scales (<a href="./references#CD009398-bbs2-0022" title="GL Assessment. British Ability Scales: Third Edition (BAS3). www.gl‐assessment.co.uk/products/bas3 (accessed 1 September 2016). ">BAS3 2011</a>); </p> </li> <li> <p>Test of Handwriting Skills ‐ Revised (<a href="./references#CD009398-bbs2-0062" title="MiloneM . Test of Handwriting Skills ‐ Revised (THS‐R). www.academictherapy.com/detailATP.tpl?eqskudatarq=8439‐7 (accessed 1 September 2016). ">Milone 2007</a>); and </p> </li> <li> <p>other similar tests, provided they are standardised for the population intended.</p> </li> </ol> </li> <li> <p>Reports of adverse effects, including:</p> <ol id="CD009398-list-0005"> <li> <p>bleeding manifestation such as prolonged bleeding time or haemorrhagic stroke;</p> </li> <li> <p>reduction of immunity such as increased incidence of infection; and</p> </li> <li> <p>other minor adverse effects such as hypersensitivity or gastrointestinal disturbances.</p> </li> </ol> </li> </ol> </p> </section> <section id="CD009398-sec-0033"> <h5 class="title">Secondary outcomes</h5> <p>Only results of validated scales (if used) were to be included.</p> <p> <ol id="CD009398-list-0006"> <li> <p>Parent‐ or teacher‐reported outcomes such as academic performance, school dropout or behaviour. </p> </li> <li> <p>Self‐reported outcomes such as self‐esteem.</p> </li> </ol> </p> </section> </section> </section> <section id="CD009398-sec-0034"> <h3 class="title">Search methods for identification of studies</h3> <p>We ran searches for this review update in October 2014 and November 2015 (see <a href="./appendices#CD009398-sec-0103">Appendix 1</a>). When possible, we limited updated searches to the period following the previous search. Review authors conducted searches for the original review (<a href="./references#CD009398-bbs2-0097" title="TanML , HoJJ , TehKH . Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders. Cochrane Database of Systematic Reviews2012, Issue 12. [DOI: 10.1002/14651858.CD009398.pub2; Art. No.: CD009398; PUBMED: 23235675 ] ">Tan 2012</a>) in July 2011 and April 2012 (see <a href="./appendices#CD009398-sec-0118">Appendix 2</a>), with no restrictions on language or date. </p> <section id="CD009398-sec-0035"> <h4 class="title">Electronic searches</h4> <p>We searched the electronic databases and trials registers listed below.</p> <p> <ol id="CD009398-list-0007"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2015, Issue 10) in the Cochrane Library, which includes the Cochrane Developmental, Psychosocial and Learning Problems Group Specialised Register. </p> </li> <li> <p>Ovid MEDLINE (1946 to November week 2 2015).</p> </li> <li> <p>Embase Ovid (1980 to 2015 week 46).</p> </li> <li> <p>PsycINFO Ovid (1967 to November week 2 2015).</p> </li> <li> <p>ERIC ProQuest (Education Resources Information Center; 1966 to current).</p> </li> <li> <p>Science Citation Index ‐ Expanded Web of Science (1970 to 19 November 2015).</p> </li> <li> <p>Social Science Citation Index Web of Science (1970 to 19 November 2015).</p> </li> <li> <p>Conference Proceedings Citation Index ‐ Science Web of Science (1990 to 19 November 2015). </p> </li> <li> <p>Conference Proceedings Citation Index ‐ Social Sciences &amp; Humanites Web of Science (1990 to 19 November 2015). </p> </li> <li> <p><i>Cochrane Database of Systematic Reviews</i> (CDSR; 2015, Issue 11 of 12) in the Cochrane Library. </p> </li> <li> <p>Database of Abstracts of Reviews of Effects (DARE; 2015, Issue 2 of 4) in the Cochrane Library. </p> </li> <li> <p>ZETOC (all available years; <a href="http://zetoc.jisc.ac.uk/wzgw?db=etoc" target="_blank">zetoc.jisc.ac.uk/wzgw?db=etoc</a>). </p> </li> <li> <p>WorldCat (limited to theses and dissertations; all available years; <a href="http://www.worldcat.org" target="_blank">worldcat.org</a>). </p> </li> <li> <p>Networked Digital Library of Theses and Dissertations (NDLTD; all available years; <a href="http://www.ndltd.org/" target="_blank">ndltd.org</a>). </p> </li> <li> <p>ClinicalTrials.gov (all available years; <a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov</a>). </p> </li> <li> <p>World Health Organization International Clinical Trials Registry Platform (WHO ICTRP; all available years; <a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch</a>). </p> </li> </ol> </p> </section> <section id="CD009398-sec-0036"> <h4 class="title">Searching other resources</h4> <p>We also searched the references of relevant reports identified by the searches.</p> </section> </section> <section id="CD009398-sec-0037"> <h3 class="title" id="CD009398-sec-0037">Data collection and analysis</h3> <section id="CD009398-sec-0038"> <h4 class="title">Selection of studies</h4> <p>Two review authors (MLT and KHT) independently screened the titles and abstracts of articles identified by the search and eliminated all studies that clearly did not meet the inclusion criteria. We retrieved full‐text reports for the remaining papers, and two review authors (MLT and KHT) screened them for inclusion. We resolved all disagreements by discussion and by including a third review author as arbitrator (JJH). Review authors were not blinded to the names of the study authors, nor to institutions or journals of publication. We documented all reasons for excluding studies assessed in full text (see <a href="./references#CD009398-sec-0141" title="">Characteristics of excluded studies</a>). </p> </section> <section id="CD009398-sec-0039"> <h4 class="title">Data extraction and management</h4> <p>MLT and KHT independently extracted data from included studies onto a specially designed data extraction form. We extracted data on study setting and methods, participant characteristics, interventions and placebo, and on outcome measures. We contacted study authors by email to seek clarification of data or to request further information about the study, when required. We resolved disagreements by discussion and by including a third review author as arbitrator (JJH). </p> </section> <section id="CD009398-sec-0040"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We used the Cochrane risk of bias tool in assessing risk of bias in included studies (<a href="./references#CD009398-bbs2-0045" title="HigginsJPT , AltmanDG , SterneJAC , on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011a</a>). Two review authors (MLT and KHT) independently assessed each study for risk of bias in sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective outcome reporting and other sources of bias. For each of these risk of bias elements, we rated studies as having low, unclear or high risk of bias. We resolved disagreements by discussion and by including a third review author as arbitrator (JJH). </p> <section id="CD009398-sec-0041"> <h5 class="title">Sequence generation</h5> <p>We rated studies as having low risk of bias if the method of sequence generation consisted of random allocating of participants by random number generator or table, toss of a coin, roll of a dice or drawing of lots. We considered studies that used non‐random sequence generation, including methods such as alternation or date of birth, as having high risk of bias. When information was insufficient to permit a judgement, we rated the study as having unclear risk of bias. </p> </section> <section id="CD009398-sec-0042"> <h5 class="title">Allocation concealment</h5> <p>We looked to see whether allocation to the intervention was concealed and could not be predicted by participants or investigator by methods such as central allocation, sequentially numbered identical drug containers or sequentially numbered sealed, opaque envelopes. We rated studies that used these methods of allocation concealment as having low risk of bias. We rated studies as having high risk of bias if investigators used open random allocation or unsealed or non‐opaque envelopes. When information was insufficient to permit a judgement, we rated the study as having unclear risk of bias. </p> </section> <section id="CD009398-sec-0043"> <h5 class="title">Blinding of participants and personnel</h5> <p>All participants and personnel can be blinded in studies examined for this review. In addition to the identical appearance of pills or capsules of PUFAs, the smell and taste should be similar, as PUFAs derived from fish sources have a distinct taste and smell. This has been shown to be detectable even when provided in capsular form (<a href="./references#CD009398-bbs2-0060" title="MakridesM , GibsonRA , McPheeAJ , YellandL , QuinlivanJ , RyanP , et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA2010;304(15):1675‐83. [DOI: 10.1001/jama.2010.1507; PUBMED: 20959577 ] ">Makrides 2010</a>). We rated blinding of participants and personnel as introducing low risk of bias if blinding was described adequately and knowledge of the allocated intervention was prevented throughout the study. We rated the study as having high risk of performance bias if researchers reported no blinding or incomplete blinding. When information was insufficient to permit a judgement, we rated the study as having unclear risk of performance bias. </p> </section> <section id="CD009398-sec-0044"> <h5 class="title">Blinding of outcome assessments</h5> <p>We first considered if the outcome was likely (such as self‐reported or parent‐reported outcomes) or not likely (such as results from standardised tests of learning abilities and some teacher‐reported outcomes) to be influenced by blinding. We then rated the study as having low risk of detection bias if blinding was described adequately and knowledge of the allocated intervention was prevented throughout the study. We rated the study as having high risk of detection bias if researchers reported no blinding, or incomplete blinding, and the outcome was likely to be influenced by this. When information was insufficient to permit a judgement, we rated the study as having unclear risk of bias. </p> </section> <section id="CD009398-sec-0045"> <h5 class="title">Incomplete outcome data</h5> <p>For each outcome of included studies, we looked for reports of attrition and exclusion, including reasons, for each intervention group. We rated studies that addressed incomplete outcome data adequately ‐ all intervention groups had similar reasons for missing data (not related to the true outcome) and numbers in all groups were balanced ‐ as having low risk of bias. We rated studies with imbalanced numbers or different reasons for missing data across groups, or that performed 'as treated' analysis with substantial departure of the intervention received from that assigned at randomisation, as having high risk of bias. When information was insufficient to permit a judgement, we rated the study as having unclear risk of bias. </p> </section> <section id="CD009398-sec-0046"> <h5 class="title">Selective outcome reporting</h5> <p>We looked for selective outcome reporting by determining whether all prespecified outcomes from the study's protocol (if available) were reported or all expected outcomes from the study were reported; in such cases, we rated studies as having low risk of bias. We rated studies that did not report all of their prespecified outcomes or did not report an expected key outcome as having high risk of bias. When information was insufficient to permit a judgement, we rated the study as having unclear risk of bias. </p> </section> <section id="CD009398-sec-0047"> <h5 class="title">Other sources of bias</h5> <p>We looked at studies to identify other sources of potential bias, such as inappropriate design, premature stopping of the study, extreme baseline imbalance or suspicion of fraud. We rated studies with such biases as having high risk of bias. We rated studies that were free of these biases as having low risk of bias. If information on which to base our judgement was insufficient, we rated the study as having unclear risk of bias. </p> </section> </section> <section id="CD009398-sec-0048"> <h4 class="title">Measures of treatment effect</h4> <section id="CD009398-sec-0049"> <h5 class="title">Continuous data</h5> <p>Treatment effects were likely to use a variety of standardised tests. For this review, as only one study provided continuous data (and therefore one test), we presented the mean difference (MD) with 95% confidence interval (CI). Our strategy for continuous data obtained through different tests or scales was set out in our protocol (<a href="./references#CD009398-bbs2-0096" title="TanML , HoJJ , TehKH . Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders. Cochrane Database of Systematic Reviews2011, Issue 10. [DOI: 10.1002/14651858.CD009398; Art. No.: CD009398] ">Tan 2011</a>) and is presented in <a href="#CD009398-tbl-0002">Table 1</a>. </p> <div class="table" id="CD009398-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Additional methods</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Measures of treatment effect</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Continuous data</b> </p> <p>Treatment effects are likely to require a variety of standardised tests. If we encounter the use of different tests for the same outcome, and we judge these to be similar enough, we will calculate the standardised mean difference (SMD) and the 95% confidence interval (CI) for each. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unit of analysis Issues</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cross‐over studies</b> </p> <p>In the analysis of studies with cross‐over design, we will first consider the possibility of carry‐over effect, whether only first period data are available, if any analysis is incorrect and if results are comparable with those of parallel‐group studies. We will use the methods suggested in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> when analysing and incorporating the trials for meta‐analysis (<a href="./references#CD009398-bbs2-0046" title="HigginsJPT , DeeksJJ , AltmanDG , on behalf of the Cochrane Statistical Methods Group. Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (Editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011b</a>, section 16.4). As a carry‐over effect is likely, given the persistence of PUFAs in tissues (<a href="./references#CD009398-bbs2-0052" title="KatanMB , DeslypereJP , vanBirgelenAP , PendersM , ZegwaardM . Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18‐month controlled study. Journal of Lipid Research1997;38(10):2012‐22. [PUBMED: 9374124] ">Katan 1997</a>), when data are available for the first period, we will use these in the analyses of learning and behavioural outcomes. However, as adverse effects are readily reversible outcomes, we could use data from both phases. </p> <p><b>Cluster‐randomised studies</b> </p> <p>We do not anticipate finding any cluster‐randomised trials for this review. However, if we do find them, we will analyse them in the unit to which they were randomised and we will adjust the effective sample size using an intracluster correlation coefficient (ICC), which we will obtain from the studies themselves, if given, or will estimate from similar studies. If we use ICCs from other sources, we will report this and will conduct sensitivity analyses to investigate the effects of variation in the ICC, as suggested in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009398-bbs2-0046" title="HigginsJPT , DeeksJJ , AltmanDG , on behalf of the Cochrane Statistical Methods Group. Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (Editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011b</a>, section16.3). </p> <p><b>Studies with multiple intervention groups</b> </p> <p>For studies with more than 2 intervention groups, we will combine the intervention (if they are similar, e.g. different dose of PUFAs or different combination of PUFAs), and control groups to create a single pair‐wise comparison. If any of the intervention groups is completely different (e.g. visual exercises, music therapy), we will exclude that particular intervention group from the analysis. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Dealing with missing data</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If more studies are included in the future, we will explore by sensitivity analysis the impact of including studies with high levels of missing data in the overall assessment of treatment effect. We will exclude from the analysis studies with missing data that have a high impact on the final results. For all outcomes, we will carry out analyses, as far as possible, on an intention‐to‐treat basis (i.e. we will attempt to include in the analyses all participants randomised to each group). Missing standard deviations (SDs) may be imputed according to the methods provided in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009398-bbs2-0046" title="HigginsJPT , DeeksJJ , AltmanDG , on behalf of the Cochrane Statistical Methods Group. Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (Editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011b</a>). </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Assessment of reporting biases</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If we identify 10 or more studies, we will use funnel plots to assess the relationships of treatment effect size and standard error. Asymmetry in the funnel plot may be a result of reporting bias, but could also be a true reflection of heterogeneity among intervention effects. We will further examine clinical heterogeneity of the studies as a possible explanation. We will compare results obtained from published studies and results from other sources (e.g. correspondence) to detect publication bias. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Subgroup analysis and investigation of heterogeneity</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>We intend to perform subgroup analyses for the primary outcome only. We will investigate the following subgroups. </p> <p> <ol id="CD009398-list-0008"> <li> <p>Different combinations of PUFAs (e.g. using only DHA or DHA combined with EPA or ALA).</p> </li> <li> <p>Type of specific learning disorder (e.g. specific reading disorder vs specific mathematical disorder). </p> </li> <li> <p>Presence of comorbidity of ADHD or autism.</p> </li> <li> <p>Age when supplementation is given (e.g. preschool or early primary school vs late primary school or secondary school). </p> </li> <li> <p>Duration of intervention (&lt; 3 months, 3 to 6 months, &gt; 6 months).</p> </li> </ol> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sensitivity analysis</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If we identify enough studies, we will perform a sensitivity analysis to assess how much the quality of the studies affects meta‐analysis results. We will conduct sensitivity analyses to find out if excluding studies with high risk of bias (as assessed by using the Cochrane tool for assessing risk of bias) has an impact on the final results. These will include studies with cross‐over design, inadequate sequence allocation and concealment, missing data or use of any imputed values. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>ADHD: attention deficit hyperactivity disorder.<br/> ALA: alpha‐lipoic acid.<br/> DHA: docosahexaenoic acid.<br/> EPA: eicosapentaenoic acid.<br/> PUFAs: polyunsaturated fatty acids. </p> </div> </div> </section> <section id="CD009398-sec-0050"> <h5 class="title">Dichotomous data</h5> <p>When dichotomous data were presented, we used the risk ratio (RR) with 95% CI.</p> </section> </section> <section id="CD009398-sec-0051"> <h4 class="title">Unit of analysis issues</h4> <p>Because we considered that a carry‐over effect was likely, we treated the cross‐over study included in this review as a parallel‐group study and therefore used only data from the first period. We identified no cluster‐randomised studies and no studies with multiple intervention groups for inclusion in this review. Our strategy for managing cross‐over studies, cluster‐randomised studies and studies with multiple intervention groups in future updates of this review was set out in our protocol (<a href="./references#CD009398-bbs2-0096" title="TanML , HoJJ , TehKH . Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders. Cochrane Database of Systematic Reviews2011, Issue 10. [DOI: 10.1002/14651858.CD009398; Art. No.: CD009398] ">Tan 2011</a>) and is presented in <a href="#CD009398-tbl-0002">Table 1</a>. </p> </section> <section id="CD009398-sec-0052"> <h4 class="title">Dealing with missing data</h4> <p>We described details of participant dropout for each of the included studies in 'Risk of bias' tables (beneath the <a href="./references#CD009398-sec-0140" title="">Characteristics of included studies</a> tables). We contacted the original authors of a particular study to request unreported summary data. We encountered no other missing data issues. Our strategy for dealing with missing data in future updates of this review was set out in our protocol (<a href="./references#CD009398-bbs2-0096" title="TanML , HoJJ , TehKH . Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders. Cochrane Database of Systematic Reviews2011, Issue 10. [DOI: 10.1002/14651858.CD009398; Art. No.: CD009398] ">Tan 2011</a>) and is presented in <a href="#CD009398-tbl-0002">Table 1</a>. </p> </section> <section id="CD009398-sec-0053"> <h4 class="title">Assessment of heterogeneity</h4> <p>Variation across selected studies may be a result of participant factors (e.g. different specific learning disorders) or study factors (e.g. study design, dropout rates, types and combinations of PUFAs used). We assessed heterogeneity across studies by visually inspecting the forest plots for overlapping CIs. We assessed for statistical heterogeneity by using the Chi² test or the I² statistic. The I² statistic describes the percentage of variability that is due to heterogeneity rather than to chance. A rough estimate for interpretation of I² follows (<a href="./references#CD009398-bbs2-0033" title="DeeksJJ , HigginsJPT , AltmanDG , on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (Editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Deeks 2011</a>). </p> <p> <ol id="CD009398-list-0009"> <li> <p>I² = 0% to 40%: might not be important.</p> </li> <li> <p>I² = 30% to 60%: may represent moderate heterogeneity.</p> </li> <li> <p>I² = 50% to 90%: may represent substantial heterogeneity.</p> </li> <li> <p>I² = 75% to 100%: represents considerable heterogeneity.</p> </li> </ol> </p> <p>The threshold for interpreting the I² value can be misleading. Therefore, we determined the importance of the observed I² by looking at the magnitude and direction of the effect, as well as the strength of evidence for clinical heterogeneity. </p> </section> <section id="CD009398-sec-0054"> <h4 class="title">Assessment of reporting biases</h4> <p>We did not have enough studies to assess for reporting bias. Our strategy for assessing reporting biases in future updates of this review was set out in our protocol (<a href="./references#CD009398-bbs2-0096" title="TanML , HoJJ , TehKH . Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders. Cochrane Database of Systematic Reviews2011, Issue 10. [DOI: 10.1002/14651858.CD009398; Art. No.: CD009398] ">Tan 2011</a>) and is presented in <a href="#CD009398-tbl-0002">Table 1</a>. </p> </section> <section id="CD009398-sec-0055"> <h4 class="title">Data synthesis</h4> <p>When we identified two or more homogenous studies for each outcome, we performed a meta‐analysis using Review Manager 5 (RevMan 5) (<a href="./references#CD009398-bbs2-0066" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 5 2014</a>) and the fixed‐effect model. We did not combine for meta‐analysis studies that were clinically distinct ‐ different treatment combinations or different measurements of learning abilities ‐ and instead presented a narrative description of study results. This narrative description included the general direction, size, consistency and strength of evidence of effect for each individual study but did not compare the effects of each study and did not present an overall conclusion. </p> <section id="CD009398-sec-0056"> <h5 class="title">Assessment of the quality of the evidence using the GRADE approach</h5> <p>For this update, we specified how we intended to use the GRADE approach, as outlined in the <a href="http://gdt.guidelinedevelopment.org/central_prod/_design/client/handbook/handbook.html" target="_blank">GRADE Handbook</a>, to assess the quality of the body of evidence related to the following outcomes. </p> <p> <ol id="CD009398-list-0010"> <li> <p>Reading, writing, spelling or mathematics scores measured by standardised tests.</p> </li> <li> <p>Reports of adverse effects.</p> </li> </ol> </p> <p>We used <a href="http://www.gradepro.org/" target="_blank">GRADEpro GDT</a> to import data from <a href="./references#CD009398-bbs2-0066" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 5 2014</a> when creating 'Summary of findings' tables. We produced a summary of the intervention effect and a measure of quality for each of the above outcomes using the GRADE approach. The GRADE approach considers five factors (study limitations, consistency of effect, imprecision, indirectness and publication bias) in assessing the quality of the body of evidence for each outcome. Evidence can be downgraded from 'high quality' by one level for serious (or by two levels for very serious) limitations, depending on assessments for risk of bias, indirectness of evidence, serious inconsistency, imprecision of effect estimates or potential publication bias. </p> <p>We downgraded the quality of evidence for adverse effects to low because of imprecision (small sample size and wide CIs) and study limitations (selective reporting in one study). Reading, writing, spelling and mathematics scores on standardised tests were not reported in the included studies. </p> </section> </section> <section id="CD009398-sec-0057"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We did not have enough studies to perform a subgroup analysis. Our strategies for subgroup analysis and investigation of heterogeneity in future updates of this review were set out in our protocol (<a href="./references#CD009398-bbs2-0096" title="TanML , HoJJ , TehKH . Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders. Cochrane Database of Systematic Reviews2011, Issue 10. [DOI: 10.1002/14651858.CD009398; Art. No.: CD009398] ">Tan 2011</a>) and are presented in <a href="#CD009398-tbl-0002">Table 1</a>. </p> </section> <section id="CD009398-sec-0058"> <h4 class="title">Sensitivity analysis</h4> <p>We did not have enough studies to perform a sensitivity analysis. Our strategy for sensitivity analysis in future updates of this review was set out in our protocol (<a href="./references#CD009398-bbs2-0096" title="TanML , HoJJ , TehKH . Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders. Cochrane Database of Systematic Reviews2011, Issue 10. [DOI: 10.1002/14651858.CD009398; Art. No.: CD009398] ">Tan 2011</a>) and is presented in <a href="#CD009398-tbl-0002">Table 1</a>. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD009398-sec-0059" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD009398-sec-0059"></div> <section id="CD009398-sec-0060"> <h3 class="title">Description of studies</h3> <section id="CD009398-sec-0061"> <h4 class="title">Results of the search</h4> <p>The original search for the previous version of this review identified 795 unique records (794 from the search of databases and one record from another source) (<a href="./references#CD009398-bbs2-0097" title="TanML , HoJJ , TehKH . Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders. Cochrane Database of Systematic Reviews2012, Issue 12. [DOI: 10.1002/14651858.CD009398.pub2; Art. No.: CD009398; PUBMED: 23235675 ] ">Tan 2012</a>). This record (<a href="./references#CD009398-bbs2-0012" title="Anon . RCT of fatty acid treatment in dyslexia. Richardson AJ. Clinical trials of fatty acid treatment in ADHD, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins, Leukotrienes and Essential Fatty Acids 2004; 70(4):383‐90. [p 387, column 1, line 29] ">Anon 2004</a>) was an unpublished study identified from a narrative review on the effects of PUFAs (<a href="./references#CD009398-bbs2-0069" title="RichardsonAJ . Clinical trials of fatty acid treatment in ADHD, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins, Leukotrienes and Essential Fatty Acids2004;70(4):383‐90. [DOI: 10.1016/j.plefa.2003.12.020; PUBMED: 15041031 ] ">Richardson 2004</a>). It was not cited, and attempts to contact the author of the narrative review failed. In addition, one paper could not be obtained even after we attempted to contact the publisher and the study author (<a href="./references#CD009398-bbs2-0014" title="RichardsonAJ , McDaidAM , CalvinCM , HigginsCJ , PuriBK . Reduced behavioural and learning problems in children with specific learning difficulties after supplementation with highly unsaturated fatty acids. European Journal of Neuroscience2000;12(Suppl 11):296. ">Richardson 2000</a>). </p> <p>Searches for this update yielded 302 unique records, including one record discovered in the reference list of a study (<a href="./references#CD009398-bbs2-0011" title="SoerensenLB , LauritzenL , EgelundN , DyssegaardCB , DalskovS , PetersenRA , et al. Increased N‐3 PUFA status is associated with improved math and reading performance in the Opus School Meal Study. Annals of Nutrition &amp; Metabolism. Proceedings of the 20th International Congress of Nutrition; 2013 September 15‐20; Granada, Spain. 2013; Vol. 63 (Suppl 1):1‐1960. [http://www.icn2013.com/pages/downloads/book_of_abstracts/!] SørensenLB , DamsgaardCT , DalskovSM , PetersenRA , EgelundN , DyssegaardCB , et al. Diet‐induced changes in iron and n‐3 fatty acid status and associations with cognitive performance in 8‐11‐year‐old Danish children: secondary analyses of the Optimal Well‐Being, Development and Health for Danish Children through a Healthy New Nordic Diet School Meal Study. The British Journal of Nutrition2015;114(10):1623‐37. [DOI: 10.1017/S0007114515003323; PUBMED: 26359192] SørensenLB , DyssegaardCB , DamsgaardCT , PetersenRA , DalskovSM , HjorthMF , et al. The effects of Nordic school meals on concentration and school performance in 8‐ to 11‐year‐old children in the OPUS School Meal Study: a cluster‐randomised, controlled, cross‐over trial. The British Journal of Nutrition2015;113(8):1280‐91. [DOI: 10.1017/S0007114515000033; PUBMED: 25791747] ">Soerensen 2013</a>). We excluded 272 irrelevant records upon reviewing titles alone, and an additional 20 records after reading the abstracts. We retrieved eight full‐text articles, which reported five studies, all of which we excluded with reasons (<a href="./references#CD009398-bbs2-0005" title="MilteCE , ParlettaN , BuckleyJD , CoatesAM , YoungRM , HowePR . Increased erythrocyte eicosapentaenoic acid and docosahexaenoic acid are associated with improved attention and behavior in children with ADHD in a randomized controlled three‐way crossover trial. Journal of Attention Disorders2015; Vol. 19, issue 11:954‐64. [DOI: 10.1177/1087054713510562; PUBMED: 24214970 ] MilteCM , ParlettaN , BuckleyJD , CoatesAM , YoungRM , HowePR . Eicosapentaenoic and docosahexaenoic acids, cognition, and behavior in children with attention‐deficit/hyperactivity disorder: a randomized controlled trial. Nutrition2012;28(6):670‐7. [DOI: 10.1016/j.nut.2011.12.009; PUBMED: 22541055] ">Milte 2012</a>; <a href="./references#CD009398-bbs2-0006" title="ParlettaN , CooperP , GentDN , PetkovJ , O'DeaK . Effects of fish oil supplementation on learning and behaviour of children from Australian indigenous remote community schools: a randomised controlled trial. Prostaglandins, Leukotrienes and Essential Fatty Acids2013;89(2‐3):71‐9. [DOI: 10.1016/j.plefa.2013.05.001; PUBMED: 23756346 ] ">Parletta 2013</a>; <a href="./references#CD009398-bbs2-0007" title="PereraH , JeewandaraKC , SeneviratneS , GurugeC . Combined omega 3 and omega 6 supplementation in children with attention‐deficit hyperactivity disorder (ADHD) refractory to methylphenidate treatment: a double‐blind, placebo‐controlled study. Journal of Child Neurology2012;27(6):747‐53. [DOI: 10.1177/0883073811435243; PUBMED: 22596014 ] ">Perera 2012</a>; <a href="./references#CD009398-bbs2-0011" title="SoerensenLB , LauritzenL , EgelundN , DyssegaardCB , DalskovS , PetersenRA , et al. Increased N‐3 PUFA status is associated with improved math and reading performance in the Opus School Meal Study. Annals of Nutrition &amp; Metabolism. Proceedings of the 20th International Congress of Nutrition; 2013 September 15‐20; Granada, Spain. 2013; Vol. 63 (Suppl 1):1‐1960. [http://www.icn2013.com/pages/downloads/book_of_abstracts/!] SørensenLB , DamsgaardCT , DalskovSM , PetersenRA , EgelundN , DyssegaardCB , et al. Diet‐induced changes in iron and n‐3 fatty acid status and associations with cognitive performance in 8‐11‐year‐old Danish children: secondary analyses of the Optimal Well‐Being, Development and Health for Danish Children through a Healthy New Nordic Diet School Meal Study. The British Journal of Nutrition2015;114(10):1623‐37. [DOI: 10.1017/S0007114515003323; PUBMED: 26359192] SørensenLB , DyssegaardCB , DamsgaardCT , PetersenRA , DalskovSM , HjorthMF , et al. The effects of Nordic school meals on concentration and school performance in 8‐ to 11‐year‐old children in the OPUS School Meal Study: a cluster‐randomised, controlled, cross‐over trial. The British Journal of Nutrition2015;113(8):1280‐91. [DOI: 10.1017/S0007114515000033; PUBMED: 25791747] ">Soerensen 2013</a>; <a href="./references#CD009398-bbs2-0010" title="RichardsonAJ , BurtonJR , SewellRP , SpreckelsenTF , MontgomeryP . Docosahexaenoic acid for reading, cognition and behavior in children aged 7‐9 years: a randomized, controlled trial (the DOLAB Study). PLoS One2012;7(9):e43909. [PUBMED: 22970149] ">Richardson 2012</a>). We found no new studies for inclusion, but we identified one ongoing study (<a href="./references#CD009398-bbs2-0015" title="ISRCTN48803273 . The DHA (docosahexaenoic acid) Oxford Learning and Behaviour (DOLAB II) study: does taking an omega 3 food supplement help children's learning and behaviour?. http://isrctn.org/ISRCTN48803273 (first received 12 March 2014). [DOI: 10.1186/ISRCTN48803273] ">ISRCTN48803273</a>) and one study awaiting classification (<a href="./references#CD009398-bbs2-0013" title="ISRCTN54901093 . A prospective, randomised, double blind, placebo controlled group study of the benefits of omega 3 fish oils (concentrated fish oils 500 milligrams) in children between the ages of 11‐16 years. www.isrctn.org/ISRCTN54901093 (first received 19 April 2012). [DOI: 10.1186/ISRCTN54901093] TanML . Cochrane Review: Enquiry about Dr Kumar's Study [personal communication]. Email to M Rhoades 10 September 2015. ">ISRCTN54901093</a>), both of which may be relevant to this review. </p> <p>To date, therefore, this review has two included studies, nine excluded studies, three studies awaiting classification and one ongoing study. See <a href="#CD009398-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD009398-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study selection flow chart." data-id="CD009398-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009398.pub3/media/CDSR/CD009398/image_n/nCD009398-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study selection flow chart.</p> </div> </div> </div> </section> <section id="CD009398-sec-0062"> <h4 class="title">Included studies</h4> <p>We have included in this update two studies (<a href="./references#CD009398-bbs2-0001" title="JohnsonM , ÖstlundS , FranssonG , KadesjöB , GillbergC . Omega‐3/omega‐6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo‐controlled trial in children and adolescents. Journal of Attention Disorders2009;12(5):394‐401. [DOI: 10.1177/1087054708316261; PUBMED: 18448859] ">Johnson 2009</a>; <a href="./references#CD009398-bbs2-0002" title="RichardsonAJ , PuriBK . A randomized double‐blind, placebo‐controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD‐related symptoms in children with specific learning disabilities. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2002;26(2):233‐9. [DOI: 10.1016/S0278‐5846(01)00254‐8; PUBMED: 11817499] ">Richardson 2002</a>), which we identified in our original search and previously excluded. Neither study reports on the primary outcome for this review, but MECIR (Methodological Expectations of Cochrane Intervention Reviews) guidance (<a href="./references#CD009398-bbs2-0029" title="ChandlerJ , ChurchillR , HigginsJ , LassersonT , ToveyD . Item C40: Excluding studies without useable data. In: Methodological standards for the conduct of new Cochrane Intervention Reviews Version 2.3 [Updated 2 December 2013]. The Cochrane Collaboration, 2013. http://editorial‐unit.cochrane.org/mecir (accessed 27 May 2016). ">Chandler 2013</a>) indicates that reported outcomes should not be considered among the inclusion criteria for a review. (See <a href="#CD009398-sec-0138">Differences between protocol and review</a>.) </p> <section id="CD009398-sec-0063"> <h5 class="title">Study population</h5> <p><a href="./references#CD009398-bbs2-0001" title="JohnsonM , ÖstlundS , FranssonG , KadesjöB , GillbergC . Omega‐3/omega‐6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo‐controlled trial in children and adolescents. Journal of Attention Disorders2009;12(5):394‐401. [DOI: 10.1177/1087054708316261; PUBMED: 18448859] ">Johnson 2009</a> included 75 children, all with a diagnosis of ADHD, out of which 32 (43% of the entire study population: 12 out of 37 in the intervention group and 20 out of 38 in the control group) had a combination reading and writing disorder, which was diagnosed on the basis of criteria from the fourth edition of the DSM (DSM‐IV) (<a href="./references#CD009398-bbs2-0019" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth. Text Revision (DSM‐IV‐TR). Washington DC: American Psychiatric Association, 2000. ">APA 2000</a>). <a href="./references#CD009398-bbs2-0002" title="RichardsonAJ , PuriBK . A randomized double‐blind, placebo‐controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD‐related symptoms in children with specific learning disabilities. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2002;26(2):233‐9. [DOI: 10.1016/S0278‐5846(01)00254‐8; PUBMED: 11817499] ">Richardson 2002</a> included 41 children with a specific reading disorder, which was diagnosed on the basis of "usual diagnostic criteria for specific developmental dyslexia". Although the criteria were not named, the description of the diagnostic criteria used would fit DSM‐IV (<a href="./references#CD009398-bbs2-0019" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth. Text Revision (DSM‐IV‐TR). Washington DC: American Psychiatric Association, 2000. ">APA 2000</a>). These children had higher than normal scores on the Conners' Parent Rating Scale (CPRS) (<a href="./references#CD009398-bbs2-0031" title="ConnersCK . Conners' Parent Rating Scales‐Revised. www.mhs.com/product.aspx?gr=cli&amp;prod=conners3&amp;id=overview (accessed 1 September 2016). ">Conners 1997</a>) but were given no formal diagnosis of ADHD. Most of the children in both studies were boys from 10 to 18 years of age. </p> </section> <section id="CD009398-sec-0064"> <h5 class="title">Settings</h5> <p>Both studies were conducted in high‐income countries ‐ <a href="./references#CD009398-bbs2-0002" title="RichardsonAJ , PuriBK . A randomized double‐blind, placebo‐controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD‐related symptoms in children with specific learning disabilities. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2002;26(2):233‐9. [DOI: 10.1016/S0278‐5846(01)00254‐8; PUBMED: 11817499] ">Richardson 2002</a> in a school setting, and <a href="./references#CD009398-bbs2-0001" title="JohnsonM , ÖstlundS , FranssonG , KadesjöB , GillbergC . Omega‐3/omega‐6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo‐controlled trial in children and adolescents. Journal of Attention Disorders2009;12(5):394‐401. [DOI: 10.1177/1087054708316261; PUBMED: 18448859] ">Johnson 2009</a> in a clinic setting. </p> </section> <section id="CD009398-sec-0065"> <h5 class="title">Intervention and comparators</h5> <p>Both studies used a combination of omega‐3 and omega‐6 supplements given as capsules, although the doses were slightly different; <a href="./references#CD009398-bbs2-0002" title="RichardsonAJ , PuriBK . A randomized double‐blind, placebo‐controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD‐related symptoms in children with specific learning disabilities. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2002;26(2):233‐9. [DOI: 10.1016/S0278‐5846(01)00254‐8; PUBMED: 11817499] ">Richardson 2002</a> used a higher omega‐6 dose compared with <a href="./references#CD009398-bbs2-0001" title="JohnsonM , ÖstlundS , FranssonG , KadesjöB , GillbergC . Omega‐3/omega‐6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo‐controlled trial in children and adolescents. Journal of Attention Disorders2009;12(5):394‐401. [DOI: 10.1177/1087054708316261; PUBMED: 18448859] ">Johnson 2009</a>. Investigators in both studies used olive oil as the placebo and provided no additional interventions. </p> </section> <section id="CD009398-sec-0066"> <h5 class="title">Study design</h5> <p><a href="./references#CD009398-bbs2-0001" title="JohnsonM , ÖstlundS , FranssonG , KadesjöB , GillbergC . Omega‐3/omega‐6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo‐controlled trial in children and adolescents. Journal of Attention Disorders2009;12(5):394‐401. [DOI: 10.1177/1087054708316261; PUBMED: 18448859] ">Johnson 2009</a> was described as a cross‐over study. The first period was an RCT, but the second period included no randomisation, and all participants received the intervention treatment. Therefore, we used first period data and treated this as a parallel‐group study. <a href="./references#CD009398-bbs2-0002" title="RichardsonAJ , PuriBK . A randomized double‐blind, placebo‐controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD‐related symptoms in children with specific learning disabilities. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2002;26(2):233‐9. [DOI: 10.1016/S0278‐5846(01)00254‐8; PUBMED: 11817499] ">Richardson 2002</a> was a parallel‐group study. </p> </section> <section id="CD009398-sec-0067"> <h5 class="title">Duration of intervention</h5> <p>Both studies gave the intervention for three months.</p> </section> <section id="CD009398-sec-0068"> <h5 class="title">Outcomes</h5> <p>Neither study reported the results of standardised tests of reading, writing, spelling or mathematics skills. </p> <p>Both studies reported adverse effects as the number of participants in each group who developed the effects. The main adverse effects reported were dyspepsia, diarrhoea, vomiting and "digestive upset". </p> <p>Both studies measured behaviour by using validated scales; <a href="./references#CD009398-bbs2-0002" title="RichardsonAJ , PuriBK . A randomized double‐blind, placebo‐controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD‐related symptoms in children with specific learning disabilities. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2002;26(2):233‐9. [DOI: 10.1016/S0278‐5846(01)00254‐8; PUBMED: 11817499] ">Richardson 2002</a> used Conners' Parent Rating Scale ‐ Long (<a href="./references#CD009398-bbs2-0031" title="ConnersCK . Conners' Parent Rating Scales‐Revised. www.mhs.com/product.aspx?gr=cli&amp;prod=conners3&amp;id=overview (accessed 1 September 2016). ">Conners 1997</a>), and <a href="./references#CD009398-bbs2-0001" title="JohnsonM , ÖstlundS , FranssonG , KadesjöB , GillbergC . Omega‐3/omega‐6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo‐controlled trial in children and adolescents. Journal of Attention Disorders2009;12(5):394‐401. [DOI: 10.1177/1087054708316261; PUBMED: 18448859] ">Johnson 2009</a> used the ADHD Rating Scale ‐ Fourth Version (ADHD‐RS‐IV) (<a href="./references#CD009398-bbs2-0036" title="Du PaulGJ , PowerTJ , AnastopoulosAD , ReidR . ADHD Rating Scale IV: Checklists, Norms and Clinical Interpretations. New York: Guilford Press, 1998. ">DuPaul 1998</a>) and the Clinical Global Impression (CGI) ‐ Severity scale (CGI‐S) (<a href="./references#CD009398-bbs2-0041" title="GuyW , National Institute of Mental Health. Psychopharmacology Research Branch, Early Clinical Drug Evaluation Program. ECDEU Assessment Manual for Psychopharmacology Revised, 1976. Rockville, Md: US Department of Health, Education and Welfare, Public Health Service, Alcohol, Drug Abuse and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs, 1976. ">Guy 1976</a>). <a href="./references#CD009398-bbs2-0001" title="JohnsonM , ÖstlundS , FranssonG , KadesjöB , GillbergC . Omega‐3/omega‐6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo‐controlled trial in children and adolescents. Journal of Attention Disorders2009;12(5):394‐401. [DOI: 10.1177/1087054708316261; PUBMED: 18448859] ">Johnson 2009</a> used several other outcome assessment tools but did not report this (see <a href="./references#CD009398-sec-0140" title="">Characteristics of included studies</a>). <a href="./references#CD009398-bbs2-0002" title="RichardsonAJ , PuriBK . A randomized double‐blind, placebo‐controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD‐related symptoms in children with specific learning disabilities. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2002;26(2):233‐9. [DOI: 10.1016/S0278‐5846(01)00254‐8; PUBMED: 11817499] ">Richardson 2002</a> reported mean scores, but <a href="./references#CD009398-bbs2-0001" title="JohnsonM , ÖstlundS , FranssonG , KadesjöB , GillbergC . Omega‐3/omega‐6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo‐controlled trial in children and adolescents. Journal of Attention Disorders2009;12(5):394‐401. [DOI: 10.1177/1087054708316261; PUBMED: 18448859] ">Johnson 2009</a> reported mean change in scores for all participants, irrespective of whether they had a learning disorder. Study authors also reported the number of participants who had a reduction in score of at least 25% on the ADHD‐RS‐IV (called 'responders' in the study) and provided data for the subgroup of participants with specific learning disorders. </p> <p>Both studies measured outcomes at three months.</p> </section> <section id="CD009398-sec-0069"> <h5 class="title">Funding source</h5> <p><a href="./references#CD009398-bbs2-0001" title="JohnsonM , ÖstlundS , FranssonG , KadesjöB , GillbergC . Omega‐3/omega‐6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo‐controlled trial in children and adolescents. Journal of Attention Disorders2009;12(5):394‐401. [DOI: 10.1177/1087054708316261; PUBMED: 18448859] ">Johnson 2009</a> was funded by the company that produced the PUFA supplement used in the study. <a href="./references#CD009398-bbs2-0002" title="RichardsonAJ , PuriBK . A randomized double‐blind, placebo‐controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD‐related symptoms in children with specific learning disabilities. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2002;26(2):233‐9. [DOI: 10.1016/S0278‐5846(01)00254‐8; PUBMED: 11817499] ">Richardson 2002</a> was funded by The Dyslexia Trust. </p> </section> </section> <section id="CD009398-sec-0070"> <h4 class="title">Excluded studies</h4> <p>We excluded nine studies (12 reports) after assessing the full text. One was an open‐label study that included no comparison group (<a href="./references#CD009398-bbs2-0004" title="LindmarkL , CloughP . A 5‐month open study with long‐chain polyunsaturated fatty acids in dyslexia. Journal of Medicinal Food2007;10(4):662‐6. [DOI: 10.1089/jmf.2006.399; PUBMED: 18158838 ] ">Lindmark 2007</a>). One was a review that included reports of unpublished, non‐randomised studies (<a href="./references#CD009398-bbs2-0008" title="PortwoodMM . The role of dietary fatty acids in children’s behaviour and learning. Nutrition and Health2006;18(3):233‐47. [DOI: 10.1177/026010600601800306; PUBMED: 17180869] ">Portwood 2006</a>). One study involved normal children (<a href="./references#CD009398-bbs2-0011" title="SoerensenLB , LauritzenL , EgelundN , DyssegaardCB , DalskovS , PetersenRA , et al. Increased N‐3 PUFA status is associated with improved math and reading performance in the Opus School Meal Study. Annals of Nutrition &amp; Metabolism. Proceedings of the 20th International Congress of Nutrition; 2013 September 15‐20; Granada, Spain. 2013; Vol. 63 (Suppl 1):1‐1960. [http://www.icn2013.com/pages/downloads/book_of_abstracts/!] SørensenLB , DamsgaardCT , DalskovSM , PetersenRA , EgelundN , DyssegaardCB , et al. Diet‐induced changes in iron and n‐3 fatty acid status and associations with cognitive performance in 8‐11‐year‐old Danish children: secondary analyses of the Optimal Well‐Being, Development and Health for Danish Children through a Healthy New Nordic Diet School Meal Study. The British Journal of Nutrition2015;114(10):1623‐37. [DOI: 10.1017/S0007114515003323; PUBMED: 26359192] SørensenLB , DyssegaardCB , DamsgaardCT , PetersenRA , DalskovSM , HjorthMF , et al. The effects of Nordic school meals on concentration and school performance in 8‐ to 11‐year‐old children in the OPUS School Meal Study: a cluster‐randomised, controlled, cross‐over trial. The British Journal of Nutrition2015;113(8):1280‐91. [DOI: 10.1017/S0007114515000033; PUBMED: 25791747] ">Soerensen 2013</a>). We excluded five studies because the children were not diagnosed with specific learning disorders (<a href="./references#CD009398-bbs2-0005" title="MilteCE , ParlettaN , BuckleyJD , CoatesAM , YoungRM , HowePR . Increased erythrocyte eicosapentaenoic acid and docosahexaenoic acid are associated with improved attention and behavior in children with ADHD in a randomized controlled three‐way crossover trial. Journal of Attention Disorders2015; Vol. 19, issue 11:954‐64. [DOI: 10.1177/1087054713510562; PUBMED: 24214970 ] MilteCM , ParlettaN , BuckleyJD , CoatesAM , YoungRM , HowePR . Eicosapentaenoic and docosahexaenoic acids, cognition, and behavior in children with attention‐deficit/hyperactivity disorder: a randomized controlled trial. Nutrition2012;28(6):670‐7. [DOI: 10.1016/j.nut.2011.12.009; PUBMED: 22541055] ">Milte 2012</a>; <a href="./references#CD009398-bbs2-0006" title="ParlettaN , CooperP , GentDN , PetkovJ , O'DeaK . Effects of fish oil supplementation on learning and behaviour of children from Australian indigenous remote community schools: a randomised controlled trial. Prostaglandins, Leukotrienes and Essential Fatty Acids2013;89(2‐3):71‐9. [DOI: 10.1016/j.plefa.2013.05.001; PUBMED: 23756346 ] ">Parletta 2013</a>; <a href="./references#CD009398-bbs2-0007" title="PereraH , JeewandaraKC , SeneviratneS , GurugeC . Combined omega 3 and omega 6 supplementation in children with attention‐deficit hyperactivity disorder (ADHD) refractory to methylphenidate treatment: a double‐blind, placebo‐controlled study. Journal of Child Neurology2012;27(6):747‐53. [DOI: 10.1177/0883073811435243; PUBMED: 22596014 ] ">Perera 2012</a>; <a href="./references#CD009398-bbs2-0009" title="RichardsonAJ , MontgomeryP . The Oxford‐Durham Study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Paediatrics2005;115(5):1360‐6. [DOI: 10.1542/peds.2004‐2164; PUBMED: 15867048] ">Richardson 2005</a>; <a href="./references#CD009398-bbs2-0010" title="RichardsonAJ , BurtonJR , SewellRP , SpreckelsenTF , MontgomeryP . Docosahexaenoic acid for reading, cognition and behavior in children aged 7‐9 years: a randomized, controlled trial (the DOLAB Study). PLoS One2012;7(9):e43909. [PUBMED: 22970149] ">Richardson 2012</a>), and another study because the intervention contained another active ingredient (carnosine) (<a href="./references#CD009398-bbs2-0003" title="KairaluomaL , NärhiV , AhonenT , WesterholmJ , AroM . Do fatty acids help in overcoming reading difficulties? A double‐blind, placebo‐controlled study of the effects of eicosapentaenoic acid and carnosine supplementation on children with dyslexia. Child: Care, Health and Development2009;35(1):112‐9. [DOI: 10.1111/j.1365‐2214.2008.00881.x; PUBMED: 18991979 ] ">Kairaluoma 2009</a>). Study authors stated that carnosine had its own potential enhancing effects on cognition, and, although it can be used to provide an antioxidant effect for PUFAs, we judged the addition of carnosine as a cointervention, which was not given to the control group. See <a href="./references#CD009398-sec-0141" title="">Characteristics of excluded studies</a>. </p> <section id="CD009398-sec-0071"> <h5 class="title">Studies awaiting classification</h5> <p>We could not obtain one abstract even after we attempted to contact the publisher and the study author (<a href="./references#CD009398-bbs2-0014" title="RichardsonAJ , McDaidAM , CalvinCM , HigginsCJ , PuriBK . Reduced behavioural and learning problems in children with specific learning difficulties after supplementation with highly unsaturated fatty acids. European Journal of Neuroscience2000;12(Suppl 11):296. ">Richardson 2000</a>). In addition, in a narrative review on the effects of PUFAs (<a href="./references#CD009398-bbs2-0069" title="RichardsonAJ . Clinical trials of fatty acid treatment in ADHD, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins, Leukotrienes and Essential Fatty Acids2004;70(4):383‐90. [DOI: 10.1016/j.plefa.2003.12.020; PUBMED: 15041031 ] ">Richardson 2004</a>), we found a reference to an anonymous, unpublished and uncited study (<a href="./references#CD009398-bbs2-0012" title="Anon . RCT of fatty acid treatment in dyslexia. Richardson AJ. Clinical trials of fatty acid treatment in ADHD, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins, Leukotrienes and Essential Fatty Acids 2004; 70(4):383‐90. [p 387, column 1, line 29] ">Anon 2004</a>). It is not clear whether <a href="./references#CD009398-bbs2-0012" title="Anon . RCT of fatty acid treatment in dyslexia. Richardson AJ. Clinical trials of fatty acid treatment in ADHD, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins, Leukotrienes and Essential Fatty Acids 2004; 70(4):383‐90. [p 387, column 1, line 29] ">Anon 2004</a> refers to a completely unpublished study or is a duplicate of <a href="./references#CD009398-bbs2-0014" title="RichardsonAJ , McDaidAM , CalvinCM , HigginsCJ , PuriBK . Reduced behavioural and learning problems in children with specific learning difficulties after supplementation with highly unsaturated fatty acids. European Journal of Neuroscience2000;12(Suppl 11):296. ">Richardson 2000</a>. We also found a record of a completed study (<a href="./references#CD009398-bbs2-0013" title="ISRCTN54901093 . A prospective, randomised, double blind, placebo controlled group study of the benefits of omega 3 fish oils (concentrated fish oils 500 milligrams) in children between the ages of 11‐16 years. www.isrctn.org/ISRCTN54901093 (first received 19 April 2012). [DOI: 10.1186/ISRCTN54901093] TanML . Cochrane Review: Enquiry about Dr Kumar's Study [personal communication]. Email to M Rhoades 10 September 2015. ">ISRCTN54901093</a>) on the WHO ICTRP. The contact author of this study has since retired, and our attempts to contact the author's institution have yielded no further information about the study. </p> </section> <section id="CD009398-sec-0072"> <h5 class="title">Ongoing studies</h5> <p>We found one ongoing study (<a href="./references#CD009398-bbs2-0015" title="ISRCTN48803273 . The DHA (docosahexaenoic acid) Oxford Learning and Behaviour (DOLAB II) study: does taking an omega 3 food supplement help children's learning and behaviour?. http://isrctn.org/ISRCTN48803273 (first received 12 March 2014). [DOI: 10.1186/ISRCTN48803273] ">ISRCTN48803273</a>), which was completed in 2015 but has not yet published study results. </p> </section> </section> </section> <section id="CD009398-sec-0073"> <h3 class="title">Risk of bias in included studies</h3> <p>We present our assessment of risk of bias in included studies in the 'Risk of bias' tables found beneath the <a href="./references#CD009398-sec-0140" title="">Characteristics of included studies</a> tables and summarise this in <a href="#CD009398-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD009398-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009398-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009398.pub3/media/CDSR/CD009398/image_n/nCD009398-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD009398-sec-0074"> <h4 class="title">Allocation</h4> <section id="CD009398-sec-0075"> <h5 class="title">Random sequence generation</h5> <p><a href="./references#CD009398-bbs2-0002" title="RichardsonAJ , PuriBK . A randomized double‐blind, placebo‐controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD‐related symptoms in children with specific learning disabilities. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2002;26(2):233‐9. [DOI: 10.1016/S0278‐5846(01)00254‐8; PUBMED: 11817499] ">Richardson 2002</a> used a computer‐generated sequence, and so we rated this study as having low risk of selection bias. We rated <a href="./references#CD009398-bbs2-0001" title="JohnsonM , ÖstlundS , FranssonG , KadesjöB , GillbergC . Omega‐3/omega‐6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo‐controlled trial in children and adolescents. Journal of Attention Disorders2009;12(5):394‐401. [DOI: 10.1177/1087054708316261; PUBMED: 18448859] ">Johnson 2009</a> as having unclear risk of selection bias, as it was not clear how the randomisation code was generated. </p> </section> <section id="CD009398-sec-0076"> <h5 class="title">Allocation concealment</h5> <p>As both studies used sequentially numbered bottles for allocation, we rated both as having low risk of selection bias related to allocation concealment. </p> </section> </section> <section id="CD009398-sec-0077"> <h4 class="title">Blinding</h4> <section id="CD009398-sec-0078"> <h5 class="title">Blinding of participants and personnel</h5> <p>Although both studies described their placebos as identical‐looking, investigators did not mention the taste. Polyunsaturated fatty acids were derived from fish in <a href="./references#CD009398-bbs2-0001" title="JohnsonM , ÖstlundS , FranssonG , KadesjöB , GillbergC . Omega‐3/omega‐6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo‐controlled trial in children and adolescents. Journal of Attention Disorders2009;12(5):394‐401. [DOI: 10.1177/1087054708316261; PUBMED: 18448859] ">Johnson 2009</a>, but the source is not clear in <a href="./references#CD009398-bbs2-0002" title="RichardsonAJ , PuriBK . A randomized double‐blind, placebo‐controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD‐related symptoms in children with specific learning disabilities. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2002;26(2):233‐9. [DOI: 10.1016/S0278‐5846(01)00254‐8; PUBMED: 11817499] ">Richardson 2002</a>. Difficulty in masking the taste led to our judgement that both studies had unclear risk of performance bias. </p> </section> <section id="CD009398-sec-0079"> <h5 class="title">Blinding of outcome assessment</h5> <p>We judged both studies to be at low risk of detection bias because it is unlikely that taste would have become known to the assessors. </p> </section> </section> <section id="CD009398-sec-0080"> <h4 class="title">Incomplete outcome data</h4> <p>Although both studies reported a substantial number of dropouts, the numbers and reasons for dropouts were similar in both groups, and in each study, analysis was based only on participants who had complete data. Consequently, we rated both studies as having low risk of attrition bias. </p> </section> <section id="CD009398-sec-0081"> <h4 class="title">Selective reporting</h4> <p>The expected outcome in both studies was the result of reading tests. However, neither study reported this information. The study protocols of both studies were not available for review authors to assess whether this outcome was predetermined. Consequently, we rated <a href="./references#CD009398-bbs2-0002" title="RichardsonAJ , PuriBK . A randomized double‐blind, placebo‐controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD‐related symptoms in children with specific learning disabilities. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2002;26(2):233‐9. [DOI: 10.1016/S0278‐5846(01)00254‐8; PUBMED: 11817499] ">Richardson 2002</a> as having unclear risk of reporting bias. <a href="./references#CD009398-bbs2-0001" title="JohnsonM , ÖstlundS , FranssonG , KadesjöB , GillbergC . Omega‐3/omega‐6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo‐controlled trial in children and adolescents. Journal of Attention Disorders2009;12(5):394‐401. [DOI: 10.1177/1087054708316261; PUBMED: 18448859] ">Johnson 2009</a> reported that the study administered other outcome measures (including reading‐writing tests) to study participants, but some of these outcomes would be reported in a separate publication. We found no other publication of this study in our search. Therefore, we rated <a href="./references#CD009398-bbs2-0001" title="JohnsonM , ÖstlundS , FranssonG , KadesjöB , GillbergC . Omega‐3/omega‐6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo‐controlled trial in children and adolescents. Journal of Attention Disorders2009;12(5):394‐401. [DOI: 10.1177/1087054708316261; PUBMED: 18448859] ">Johnson 2009</a> as having high risk of reporting bias. </p> </section> <section id="CD009398-sec-0082"> <h4 class="title">Other potential sources of bias</h4> <p>We detected no other potential sources of bias. Although <a href="./references#CD009398-bbs2-0001" title="JohnsonM , ÖstlundS , FranssonG , KadesjöB , GillbergC . Omega‐3/omega‐6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo‐controlled trial in children and adolescents. Journal of Attention Disorders2009;12(5):394‐401. [DOI: 10.1177/1087054708316261; PUBMED: 18448859] ">Johnson 2009</a> was funded by the manufacturer of the PUFAs, and the company was clearly involved in the randomisation and allocation concealment process, we did not consider funding to be an additional source of bias (<a href="./references#CD009398-bbs2-0045" title="HigginsJPT , AltmanDG , SterneJAC , on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011a</a>, section 8.15.15). We assessed independently the specific aspects of methods (sequence generation and allocation concealment) that might have been influenced by vested interests. Thus, we rated both studies as having low risk of other sources of bias. </p> </section> </section> <section id="CD009398-sec-0083"> <h3 class="title" id="CD009398-sec-0083">Effects of interventions</h3> <p>See: <a href="./full#CD009398-tbl-0001"><b>Summary of findings for the main comparison</b> Summary of findings table</a> </p> <section id="CD009398-sec-0084"> <h4 class="title">Comparison: PUFAs versus placebo</h4> <p>The summary of effects of the intervention can be found in <a href="./full#CD009398-tbl-0001">summary of findings Table for the main comparison</a>. </p> <section id="CD009398-sec-0085"> <h5 class="title">Primary outcomes</h5> <section id="CD009398-sec-0086"> <h6 class="title">Reading, writing, spelling and mathematics scores</h6> <p>No studies reported data on this outcome.</p> </section> <section id="CD009398-sec-0087"> <h6 class="title">Reporting of adverse effects</h6> <p>The adverse effects reported in both studies were gastrointestinal disturbances. For <a href="./references#CD009398-bbs2-0001" title="JohnsonM , ÖstlundS , FranssonG , KadesjöB , GillbergC . Omega‐3/omega‐6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo‐controlled trial in children and adolescents. Journal of Attention Disorders2009;12(5):394‐401. [DOI: 10.1177/1087054708316261; PUBMED: 18448859] ">Johnson 2009</a>, we used data from the first period for all participants, irrespective of the diagnosis, when analysing adverse effects because these effects would not be expected to be specific only to those with specific learning disorders. There was no difference in the risk of gastrointestinal disturbances when comparing the PUFA group with the placebo group (RR 1.43, 95% CI 0.25 to 8.15; I² = 0%; two studies, 116 children; low‐quality evidence; see <a href="#CD009398-fig-0003">Figure 3</a>). We downgraded the evidence to low quality because of imprecision and study limitations. </p> <div class="figure" id="CD009398-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 PUFAs versus placebo, outcome: 1.1 Adverse effects (gastrointestinal disturbances)." data-id="CD009398-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009398.pub3/media/CDSR/CD009398/image_n/nCD009398-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 PUFAs versus placebo, outcome: 1.1 Adverse effects (gastrointestinal disturbances). </p> </div> </div> </div> </section> </section> <section id="CD009398-sec-0088"> <h5 class="title">Secondary outcomes</h5> <section id="CD009398-sec-0089"> <h6 class="title">Parent‐ or teacher‐reported outcomes</h6> <p>Both studies reported the results of ADHD symptom scores. <a href="./references#CD009398-bbs2-0002" title="RichardsonAJ , PuriBK . A randomized double‐blind, placebo‐controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD‐related symptoms in children with specific learning disabilities. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2002;26(2):233‐9. [DOI: 10.1016/S0278‐5846(01)00254‐8; PUBMED: 11817499] ">Richardson 2002</a> used the CPRS ‐ Long (<a href="./references#CD009398-bbs2-0031" title="ConnersCK . Conners' Parent Rating Scales‐Revised. www.mhs.com/product.aspx?gr=cli&amp;prod=conners3&amp;id=overview (accessed 1 September 2016). ">Conners 1997</a>), and <a href="./references#CD009398-bbs2-0001" title="JohnsonM , ÖstlundS , FranssonG , KadesjöB , GillbergC . Omega‐3/omega‐6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo‐controlled trial in children and adolescents. Journal of Attention Disorders2009;12(5):394‐401. [DOI: 10.1177/1087054708316261; PUBMED: 18448859] ">Johnson 2009</a> used the ADHD‐RS‐IV, Parent Version (<a href="./references#CD009398-bbs2-0036" title="Du PaulGJ , PowerTJ , AnastopoulosAD , ReidR . ADHD Rating Scale IV: Checklists, Norms and Clinical Interpretations. New York: Guilford Press, 1998. ">DuPaul 1998</a>). <a href="./references#CD009398-bbs2-0002" title="RichardsonAJ , PuriBK . A randomized double‐blind, placebo‐controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD‐related symptoms in children with specific learning disabilities. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2002;26(2):233‐9. [DOI: 10.1016/S0278‐5846(01)00254‐8; PUBMED: 11817499] ">Richardson 2002</a> reported mean ADHD symptom scores and revealed no differences in PUFA and placebo groups after 12 weeks of intervention (MD ‐5.20, 95% CI ‐12.26 to 1.86; 29 children). However, <a href="./references#CD009398-bbs2-0001" title="JohnsonM , ÖstlundS , FranssonG , KadesjöB , GillbergC . Omega‐3/omega‐6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo‐controlled trial in children and adolescents. Journal of Attention Disorders2009;12(5):394‐401. [DOI: 10.1177/1087054708316261; PUBMED: 18448859] ">Johnson 2009</a> reported the number of responders (those with &gt; 25% reduction in ADHD scores) for the subgroup with specific learning disorders, revealing more responders in the PUFA group than in the placebo group. We have contacted the authors of <a href="./references#CD009398-bbs2-0001" title="JohnsonM , ÖstlundS , FranssonG , KadesjöB , GillbergC . Omega‐3/omega‐6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo‐controlled trial in children and adolescents. Journal of Attention Disorders2009;12(5):394‐401. [DOI: 10.1177/1087054708316261; PUBMED: 18448859] ">Johnson 2009</a> to request summary data for the subgroup with specific learning disorders but have not yet received a response. Therefore, for this outcome, no meta‐analysis was possible because one study reported continuous data, and the other dichotomous data. </p> </section> <section id="CD009398-sec-0090"> <h6 class="title">Self‐reported outcomes</h6> <p>No studies reported data on this outcome.</p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD009398-sec-0091" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD009398-sec-0091"></div> <section id="CD009398-sec-0092"> <h3 class="title" id="CD009398-sec-0092">Summary of main results</h3> <p>Two small studies met the eligibility criteria for this review, but neither measured the primary learning outcomes. Therefore, to date, no information is available to guide us in the use of polyunsaturated fatty acids (PUFAs) for children with specific learning disorders. </p> <p>The little evidence that we have reveals that PUFAs did not increase the risk of developing gastrointestinal disturbance compared with placebo, when taken for three months. Included studies did not report other adverse effects. </p> </section> <section id="CD009398-sec-0093"> <h3 class="title" id="CD009398-sec-0093">Overall completeness and applicability of evidence</h3> <p>We were unable to find any studies that directly assessed the use of PUFAs and their effects on learning outcomes of children with specific learning disorders. The two included studies reported only attention deficit hyperactivity disorder (ADHD)‐related behavioural outcomes. Given the extensive overlap of specific learning disorders and ADHD, it is important to know whether PUFAs have any effects on learning outcomes ‐ the core problem associated with specific learning disorders. Improvement in behaviour does not necessarily result in improvement in reading, spelling, writing or mathematics skills. </p> <p>When other active elements are added to the PUFA supplement, such as carnosine in <a href="./references#CD009398-bbs2-0003" title="KairaluomaL , NärhiV , AhonenT , WesterholmJ , AroM . Do fatty acids help in overcoming reading difficulties? A double‐blind, placebo‐controlled study of the effects of eicosapentaenoic acid and carnosine supplementation on children with dyslexia. Child: Care, Health and Development2009;35(1):112‐9. [DOI: 10.1111/j.1365‐2214.2008.00881.x; PUBMED: 18991979 ] ">Kairaluoma 2009</a>, and no comparative placebos are given, it is not possible to attribute any effects of the intervention to PUFAs. Our search found many studies of PUFAs given to help children with unspecified learning problems or to improve learning in normal children. Our review excluded studies that examined children without a diagnosis of specific learning disorders. Therefore, this review is unable to address the question of whether PUFAs have any effect on poorly performing or normal children in mainstream education. </p> </section> <section id="CD009398-sec-0094"> <h3 class="title" id="CD009398-sec-0094">Quality of the evidence</h3> <p>We used the GRADE approach to assess the quality of the evidence for adverse effects. We downgraded the evidence by two levels to low quality because of small sample size and few events (imprecision), as well as high risk of reporting bias (study limitations), in <a href="./references#CD009398-bbs2-0001" title="JohnsonM , ÖstlundS , FranssonG , KadesjöB , GillbergC . Omega‐3/omega‐6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo‐controlled trial in children and adolescents. Journal of Attention Disorders2009;12(5):394‐401. [DOI: 10.1177/1087054708316261; PUBMED: 18448859] ">Johnson 2009</a>. </p> </section> <section id="CD009398-sec-0095"> <h3 class="title" id="CD009398-sec-0095">Potential biases in the review process</h3> <p>For three studies, it remains unclear whether they meet our inclusion criteria (see <a href="./references#CD009398-sec-0142" title="">Characteristics of studies awaiting classification</a>). We were able to retrieve neither the abstract nor the full text for one study that might qualify for inclusion in this review (<a href="./references#CD009398-bbs2-0014" title="RichardsonAJ , McDaidAM , CalvinCM , HigginsCJ , PuriBK . Reduced behavioural and learning problems in children with specific learning difficulties after supplementation with highly unsaturated fatty acids. European Journal of Neuroscience2000;12(Suppl 11):296. ">Richardson 2000</a>). This article is no longer available from the publisher, and our attempts to contact the study author were unsuccessful. Our handsearch of the citations of other studies revealed that this study is often cited together with <a href="./references#CD009398-bbs2-0002" title="RichardsonAJ , PuriBK . A randomized double‐blind, placebo‐controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD‐related symptoms in children with specific learning disabilities. Progress in Neuro‐Psychopharmacology and Biological Psychiatry2002;26(2):233‐9. [DOI: 10.1016/S0278‐5846(01)00254‐8; PUBMED: 11817499] ">Richardson 2002</a>; therefore, it is possible that the two citations may apply to the same study. Also, in a review of clinical studies on PUFAs in children with ADHD and dyslexia (<a href="./references#CD009398-bbs2-0069" title="RichardsonAJ . Clinical trials of fatty acid treatment in ADHD, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins, Leukotrienes and Essential Fatty Acids2004;70(4):383‐90. [DOI: 10.1016/j.plefa.2003.12.020; PUBMED: 15041031 ] ">Richardson 2004</a>), we found one report of an unpublished randomised controlled trial (RCT) of 102 children eight to 12 years of age who had reading difficulties (<a href="./references#CD009398-bbs2-0012" title="Anon . RCT of fatty acid treatment in dyslexia. Richardson AJ. Clinical trials of fatty acid treatment in ADHD, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins, Leukotrienes and Essential Fatty Acids 2004; 70(4):383‐90. [p 387, column 1, line 29] ">Anon 2004</a>). No citation is available for this unpublished report, and we could not contact the author of the review to request further information. We could not find the results of another completed study, retrospectively registered on the World Health Organization International Clinical Trials Registry Platform (WHO ICTRP) (<a href="./references#CD009398-bbs2-0013" title="ISRCTN54901093 . A prospective, randomised, double blind, placebo controlled group study of the benefits of omega 3 fish oils (concentrated fish oils 500 milligrams) in children between the ages of 11‐16 years. www.isrctn.org/ISRCTN54901093 (first received 19 April 2012). [DOI: 10.1186/ISRCTN54901093] TanML . Cochrane Review: Enquiry about Dr Kumar's Study [personal communication]. Email to M Rhoades 10 September 2015. ">ISRCTN54901093</a>), which may have met our inclusion criteria. The contact author has retired, and we could obtain no further information about the study from the contact institution. </p> <p>For this update, we reviewed our eligibility criteria and made a decision to leave as they were the prespecified strict criteria for the diagnosis of specific learning disorders. We avoided taking a pragmatic approach to the definition of learning disorders because children might not learn for a variety of other reasons, including other nutritional and environmental factors, such as socioeconomic status and access to school, and the presence of other neurodevelopmental disorders, especially ADHD (<a href="./references#CD009398-bbs2-0037" title="DuPaulGJ , GormleyMJ , LaracySD . Comorbidity of LD and ADHD: implications of DSM‐5 for assessment and treatment. Journal of Learning Disabilities2013;46(1):43‐51. [DOI: 10.1177/0022219412464351; PUBMED: 23144063] ">DuPaul 2013</a>; <a href="./references#CD009398-bbs2-0043" title="HamiltonSS , GlascoeFP . Evaluation of children with reading difficulties. American Family Physician2006;74(12):2079‐84. [PUBMED: 17186715] ">Hamilton 2006</a>). We believe our strict criteria strengthen this review. </p> </section> <section id="CD009398-sec-0096"> <h3 class="title" id="CD009398-sec-0096">Agreements and disagreements with other studies or reviews</h3> <p>One of the excluded studies that involved children with dyslexia reported that supplementation with PUFAs had a positive effect on speed of reading and decoding fluency (<a href="./references#CD009398-bbs2-0004" title="LindmarkL , CloughP . A 5‐month open study with long‐chain polyunsaturated fatty acids in dyslexia. Journal of Medicinal Food2007;10(4):662‐6. [DOI: 10.1089/jmf.2006.399; PUBMED: 18158838 ] ">Lindmark 2007</a>). However, this study was small (17 children) and was not randomised, controlled or blinded. Another excluded study, which was an RCT (<a href="./references#CD009398-bbs2-0003" title="KairaluomaL , NärhiV , AhonenT , WesterholmJ , AroM . Do fatty acids help in overcoming reading difficulties? A double‐blind, placebo‐controlled study of the effects of eicosapentaenoic acid and carnosine supplementation on children with dyslexia. Child: Care, Health and Development2009;35(1):112‐9. [DOI: 10.1111/j.1365‐2214.2008.00881.x; PUBMED: 18991979 ] ">Kairaluoma 2009</a>), examined effects of PUFAs and carnosine on 61 children with specific learning disorders and found no evidence of benefit for reading, spelling or mathematics outcomes. </p> <p>No systematic reviews have examined PUFAs and specific learning disorders, but two narrative reviews combined clinical studies on dyslexia, dyspraxia and ADHD (<a href="./references#CD009398-bbs2-0069" title="RichardsonAJ . Clinical trials of fatty acid treatment in ADHD, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins, Leukotrienes and Essential Fatty Acids2004;70(4):383‐90. [DOI: 10.1016/j.plefa.2003.12.020; PUBMED: 15041031 ] ">Richardson 2004</a>; <a href="./references#CD009398-bbs2-0073" title="SchuchardtJP , HussM , Stauss‐GraboM , HahnA . Significance of long‐chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children. European Journal of Paediatrics2010;169(2):149‐64. [DOI: 10.1007/s00431‐009‐1035‐8; PUBMED: 19672626 ] ">Schuchardt 2010</a>). These reviews concluded that PUFAs may be beneficial for common neurodevelopmental conditions such as these. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD009398-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009398.pub3/media/CDSR/CD009398/urn:x-wiley:14651858:media:CD009398:CD009398-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009398.pub3/media/CDSR/CD009398/image_t/tCD009398-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study selection flow chart." data-id="CD009398-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009398.pub3/media/CDSR/CD009398/image_n/nCD009398-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study selection flow chart.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009398.pub3/full#CD009398-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009398.pub3/media/CDSR/CD009398/image_n/nCD009398-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009398-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009398.pub3/media/CDSR/CD009398/urn:x-wiley:14651858:media:CD009398:CD009398-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009398.pub3/media/CDSR/CD009398/image_t/tCD009398-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009398-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009398.pub3/media/CDSR/CD009398/image_n/nCD009398-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009398.pub3/full#CD009398-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009398.pub3/media/CDSR/CD009398/image_n/nCD009398-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009398-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009398.pub3/media/CDSR/CD009398/urn:x-wiley:14651858:media:CD009398:CD009398-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009398.pub3/media/CDSR/CD009398/image_t/tCD009398-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 PUFAs versus placebo, outcome: 1.1 Adverse effects (gastrointestinal disturbances)." data-id="CD009398-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009398.pub3/media/CDSR/CD009398/image_n/nCD009398-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 PUFAs versus placebo, outcome: 1.1 Adverse effects (gastrointestinal disturbances). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009398.pub3/full#CD009398-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009398.pub3/media/CDSR/CD009398/image_n/nCD009398-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009398-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009398.pub3/media/CDSR/CD009398/urn:x-wiley:14651858:media:CD009398:CD009398-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009398.pub3/media/CDSR/CD009398/image_t/tCD009398-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 PUFAs versus placebo, Outcome 1 Adverse effects (gastrointestinal disturbances)." data-id="CD009398-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009398.pub3/media/CDSR/CD009398/image_n/nCD009398-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 PUFAs versus placebo, Outcome 1 Adverse effects (gastrointestinal disturbances).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009398.pub3/references#CD009398-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009398.pub3/media/CDSR/CD009398/image_n/nCD009398-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009398-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009398.pub3/media/CDSR/CD009398/urn:x-wiley:14651858:media:CD009398:CD009398-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009398.pub3/media/CDSR/CD009398/image_t/tCD009398-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 PUFAs versus placebo, Outcome 2 Behavioural effects (ADHD symptoms score)." data-id="CD009398-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009398.pub3/media/CDSR/CD009398/image_n/nCD009398-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 PUFAs versus placebo, Outcome 2 Behavioural effects (ADHD symptoms score).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009398.pub3/references#CD009398-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009398.pub3/media/CDSR/CD009398/image_n/nCD009398-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD009398-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Summary of findings table</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>PUFAs vs placebo</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children with specific learning disorders<br/> <b>Setting:</b> community<br/> <b>Intervention:</b> PUFAs<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with PUFAs</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standardised tests of reading, writing, spelling or mathematics skills (overall)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>None of the included studies assessed effects on standardised tests of reading, writing, spelling or mathematics skills </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Adverse effect (gastrointestinal disturbance)<br/> Follow‐up: mean 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.43</b> <br/> (0.25 to 8.15) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>116<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>35 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>50 per 1000<br/> (9 to 286) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> CI: confidence interval; PUFAs: polyunsaturated fatty acids; RCTs: randomised controlled trials; RR: risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality.</b> We are very confident that the true effect lies close to that of the estimate of effect.<br/> <b>Moderate quality.</b> We are moderately confident in the effect estimate. The true effect is likely to be close to the estimate of effect but may be substantially different.<br/> <b>Low quality.</b> Our confidence in the effect estimate is limited. The true effect may be substantially different from the estimate of effect.<br/> <b>Very low quality.</b> We have very little confidence in the effect estimate. The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Small sample size with few events. Extremely wide CIs.<br/> <sup>b</sup>Selective outcome reporting in one study. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Summary of findings table</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009398.pub3/full#CD009398-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009398-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Additional methods</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Measures of treatment effect</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Continuous data</b> </p> <p>Treatment effects are likely to require a variety of standardised tests. If we encounter the use of different tests for the same outcome, and we judge these to be similar enough, we will calculate the standardised mean difference (SMD) and the 95% confidence interval (CI) for each. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unit of analysis Issues</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cross‐over studies</b> </p> <p>In the analysis of studies with cross‐over design, we will first consider the possibility of carry‐over effect, whether only first period data are available, if any analysis is incorrect and if results are comparable with those of parallel‐group studies. We will use the methods suggested in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> when analysing and incorporating the trials for meta‐analysis (<a href="./references#CD009398-bbs2-0046" title="HigginsJPT , DeeksJJ , AltmanDG , on behalf of the Cochrane Statistical Methods Group. Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (Editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011b</a>, section 16.4). As a carry‐over effect is likely, given the persistence of PUFAs in tissues (<a href="./references#CD009398-bbs2-0052" title="KatanMB , DeslypereJP , vanBirgelenAP , PendersM , ZegwaardM . Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18‐month controlled study. Journal of Lipid Research1997;38(10):2012‐22. [PUBMED: 9374124] ">Katan 1997</a>), when data are available for the first period, we will use these in the analyses of learning and behavioural outcomes. However, as adverse effects are readily reversible outcomes, we could use data from both phases. </p> <p><b>Cluster‐randomised studies</b> </p> <p>We do not anticipate finding any cluster‐randomised trials for this review. However, if we do find them, we will analyse them in the unit to which they were randomised and we will adjust the effective sample size using an intracluster correlation coefficient (ICC), which we will obtain from the studies themselves, if given, or will estimate from similar studies. If we use ICCs from other sources, we will report this and will conduct sensitivity analyses to investigate the effects of variation in the ICC, as suggested in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009398-bbs2-0046" title="HigginsJPT , DeeksJJ , AltmanDG , on behalf of the Cochrane Statistical Methods Group. Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (Editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011b</a>, section16.3). </p> <p><b>Studies with multiple intervention groups</b> </p> <p>For studies with more than 2 intervention groups, we will combine the intervention (if they are similar, e.g. different dose of PUFAs or different combination of PUFAs), and control groups to create a single pair‐wise comparison. If any of the intervention groups is completely different (e.g. visual exercises, music therapy), we will exclude that particular intervention group from the analysis. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Dealing with missing data</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If more studies are included in the future, we will explore by sensitivity analysis the impact of including studies with high levels of missing data in the overall assessment of treatment effect. We will exclude from the analysis studies with missing data that have a high impact on the final results. For all outcomes, we will carry out analyses, as far as possible, on an intention‐to‐treat basis (i.e. we will attempt to include in the analyses all participants randomised to each group). Missing standard deviations (SDs) may be imputed according to the methods provided in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009398-bbs2-0046" title="HigginsJPT , DeeksJJ , AltmanDG , on behalf of the Cochrane Statistical Methods Group. Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (Editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011b</a>). </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Assessment of reporting biases</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If we identify 10 or more studies, we will use funnel plots to assess the relationships of treatment effect size and standard error. Asymmetry in the funnel plot may be a result of reporting bias, but could also be a true reflection of heterogeneity among intervention effects. We will further examine clinical heterogeneity of the studies as a possible explanation. We will compare results obtained from published studies and results from other sources (e.g. correspondence) to detect publication bias. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Subgroup analysis and investigation of heterogeneity</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>We intend to perform subgroup analyses for the primary outcome only. We will investigate the following subgroups. </p> <p> <ol id="CD009398-list-0008"> <li> <p>Different combinations of PUFAs (e.g. using only DHA or DHA combined with EPA or ALA).</p> </li> <li> <p>Type of specific learning disorder (e.g. specific reading disorder vs specific mathematical disorder). </p> </li> <li> <p>Presence of comorbidity of ADHD or autism.</p> </li> <li> <p>Age when supplementation is given (e.g. preschool or early primary school vs late primary school or secondary school). </p> </li> <li> <p>Duration of intervention (&lt; 3 months, 3 to 6 months, &gt; 6 months).</p> </li> </ol> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sensitivity analysis</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If we identify enough studies, we will perform a sensitivity analysis to assess how much the quality of the studies affects meta‐analysis results. We will conduct sensitivity analyses to find out if excluding studies with high risk of bias (as assessed by using the Cochrane tool for assessing risk of bias) has an impact on the final results. These will include studies with cross‐over design, inadequate sequence allocation and concealment, missing data or use of any imputed values. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="1"> <div class="table-footnote"> <p>ADHD: attention deficit hyperactivity disorder.<br/> ALA: alpha‐lipoic acid.<br/> DHA: docosahexaenoic acid.<br/> EPA: eicosapentaenoic acid.<br/> PUFAs: polyunsaturated fatty acids. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Additional methods</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009398.pub3/full#CD009398-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009398-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">PUFAs versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Adverse effects (gastrointestinal disturbances) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>116</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.43 [0.25, 8.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Behavioural effects (ADHD symptoms score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">PUFAs versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009398.pub3/references#CD009398-tbl-0003">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD009398.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD009398-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD009398-note-0006">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD009398-note-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="ja#CD009398-note-0004">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD009398-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD009398-note-0005">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD009398-note-0002">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009398\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009398\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009398\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009398\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009398\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009398\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009398\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009398\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009398\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009398\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009398\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009398\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009398\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009398\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009398\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009398\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009398\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009398\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=9nGOjNGw&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009398.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009398.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD009398.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD009398.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009398.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740724898345"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009398.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740724898349"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009398.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e6e0c2fe1f4ca',t:'MTc0MDcyNDg5OC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 